PSY58 Responsiveness of the Treatment Satisfaction with Medicines Questionnaire (Satmed-Q) in a Longitudinal Sample of Patients with Neuropathic Pain (Englisch)
- Neue Suche nach: Rejas, J.
- Neue Suche nach: Ruiz, M. A.
- Neue Suche nach: Pardo, A.
- Neue Suche nach: Ruiz, L.
- Neue Suche nach: Soto, J.
- Neue Suche nach: Rejas, J.
- Neue Suche nach: Ruiz, M. A.
- Neue Suche nach: Pardo, A.
- Neue Suche nach: Ruiz, L.
- Neue Suche nach: Soto, J.
In:
VALUE IN HEALTH
;
14
, 7
;
A420-A421
;
2011
-
ISSN:
- Aufsatz (Zeitschrift) / Print
-
Titel:PSY58 Responsiveness of the Treatment Satisfaction with Medicines Questionnaire (Satmed-Q) in a Longitudinal Sample of Patients with Neuropathic Pain
-
Beteiligte:Rejas, J. ( Autor:in ) / Ruiz, M. A. ( Autor:in ) / Pardo, A. ( Autor:in ) / Ruiz, L. ( Autor:in ) / Soto, J. ( Autor:in )
-
Erschienen in:VALUE IN HEALTH ; 14, 7 ; A420-A421
-
Verlag:
- Neue Suche nach: Blackwell Publishing Ltd
-
Erscheinungsdatum:01.01.2011
-
Format / Umfang:A420-A421
-
ISSN:
-
Medientyp:Aufsatz (Zeitschrift)
-
Format:Print
-
Sprache:Englisch
- Neue Suche nach: 610
- Weitere Informationen zu Dewey Decimal Classification
-
Klassifikation:
DDC: 610 -
Datenquelle:
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
Inhaltsverzeichnis – Band 14, Ausgabe 7
Zeige alle Jahrgänge und Ausgaben
Die Inhaltsverzeichnisse werden automatisch erzeugt und basieren auf den im Index des TIB-Portals verfügbaren Einzelnachweisen der enthaltenen Beiträge. Die Anzeige der Inhaltsverzeichnisse kann daher unvollständig oder lückenhaft sein.
- A234
-
DA1 Artificial Neural Network Meta-Models in Cost-Effectiveness analysis of intensive Blood-Glucose Control: A Case Study Applied to the UK prospective Diabetes Study (UKPDS) Individual Patient outcome Simulation ModelAlam, M. / Briggs, A. et al. | 2011
- A235
-
PC2 Estimation of Productivity Costs Using the Friction Cost Method: New Evidence Using National DataErdogan-Ciftci, E. / Koopmanschap, M. A. et al. | 2011
- A236
-
PR3 Industry Preparedness against German reformsDevienne, E. / White, R. / Mukku, S. et al. | 2011
- A237
-
MT4 Mixed Treatment Comparisons Using Aggregate- and individual-Participant Level Data: An Efficient Use of Evidence for Cost-Effectiveness ModellingSaramago, P. / Sutton, A. J. / Cooper, N. J. / Manca, A. et al. | 2011
- A238
-
UT1 Combining DCE and TTO Into A Single Value FunctionVan Hout, B. A. / Oppe, M. et al. | 2011
- A239
-
VI3 Sequential Treatment of Follicular Non-Hodgkin Lymphoma: Cost-Effectiveness and Value of informationSoini, E. J. / Martikainen, J. A. / Vihervaara, V. / Mustonen, K. / Nousiainen, T. et al. | 2011
- A241
-
MA1 Mapping the EQ-5D Index from I-QOL in Idiopathic and Neurogenic OAB Patients: Results from A Cross-Sectional Study in the United States and Four European CountriesKay, S. / Tolley, K. / Globe, D. / Piercy, J. / Anderson, P. et al. | 2011
- A242
-
MO2 Extrapolation in Oncology Modelling: Novel Methods for Novel CompoundsAnnemans, L. / Asukai, Y. / Barzey, V. / Kotapati, S. / Lees, M. / Van Baardewijk, M. / Wang, Q. / Batty, A. J. / Fisher, D. et al. | 2011
- A243
-
RS3 Evidence, Process or Context? Examining The Factors That Drive Coverage Decisions Of Pharmaceuticals By Health Technology Assessment Bodies In EuropeCerri, K. / Ferná / ndez, J. L. / Knapp, M. et al. | 2011
- A244
-
PMD4 Expert Elicitation to Populate Early Health Economic Models of Medical Diagnostic Devices in DevelopmentHaakma, W. / Bojke, L. / Steuten, L. / Ijzerman, M. et al. | 2011
- A247
-
PMD20 Cost Analysis of Rechargeable Deep Brain Stimulator in DystoniaPr Coubes, P. / Fluck, L. / Topouchian, A. et al. | 2011
- A248
-
PMD25 Cost-Effectiveness of Transcatheter Aortic Valve Implantation (TAVI) in High-Risk or Inoperable Patients with Symptomatic Aortic Valve Stenosis in SpainFerreira-Gonzá / lez, I. / Serra, V. / Abdul, O. / Lizan, L. / Paz, S. / Banz, K. / Sureda, C. / Igual, A. / Garcia del Blanco, B. et al. | 2011
- A249
-
PMD31 Economic Evaluation of Primovist versus Extracellular Contrast in Imaging of Liver Metastases of Colorectal OriginCastell, J. / Bernal, C. / De Marcos, J. x. / Cugat, E. / Ramó / n, E. / Tellado, J. M. et al. | 2011
- A250
-
PMD37 Cost-Effectiveness of the Ex-Press Glaucoma Filtration Device in FranceDe jong, L. / Lafuma, A. / Clé / ment, O. / Aguade, A. S. / Berdeaux, G. et al. | 2011
- A251
-
PMD42 Cost-Effectiveness of Using the UGT1A1 Pharmacogenetic Test to Reduce the Incidence of Irinotecan Chemotherapy-related Febrile NeutropaeniaShabaruddin, F. H. / Elliott, R. A. / Tappenden, P. / Payne, K. et al. | 2011
- A253
-
PMD54 Resource Utilisation Related to Catheter-associated Urinary Tract infections in Swedish Spinal injury PatientsBruce, S. / Lö / froth, E. / Knutsson, B. / Bö / rstell, T. / Myré / n, K. J. et al. | 2011
- A254
-
PMD59 Complicated Parkinson'S Disease: Discrete Choice Analysis to Assess Patients' Preferences. A Pilot StudyLloyd, A. J. / Herdman, M. / Gonzalez, P. et al. | 2011
- A255
-
PMD64 The Effect of Supplementary Fees on the Diffusion of Medical Devices in the German System of Diagnosis related Groups (G-Drg): The Case of Drug-Eluting Stents in Patients with Acute Myocardial InfarctionBä / umler, M. et al. | 2011
- A257
-
PMD75 Patient Self-Testing of Oral Anticoagulation Therapy by CoaguChek® XS System. Rapid Health Technology Assessment in Slovak Health Care EnvironmentVisnansky, M. / Mesaros, S. et al. | 2011
- A258
-
PMD80 Patient Demographics and Surgical Expenditure in Hernia repair Surgical Cohorts Using A retrospective Nationwide Patient DatabaseHargreaves, J. A. / Nair, K. V. / Ghushchyan, V. H. / Allen, R. R. / Mcqueen, R. B. / Robinson, T. et al. | 2011
- A259
-
PMD85 Sleep Questionnaires Discriminate Between Participants With and Without Overactive Bladder SymptomsMargolis, M. K. / Coyne, K. / Jumadilova, Z. et al. | 2011
- A260
-
PSU5 Risk of Arthritis as A Predictor for the Misdiagnosis of Chondrolysis: An International Analysis of Clinical OutcomesSmith, J. C. / Provencher, M. T. / Solomon, D. J. / Navaie, M. et al. | 2011
- A261
-
PSU10 Economic Evaluation of Magnetic Resonance Guided Focused Ultrasound in Patients with Uterine Fibroids in GermanyAlvarez-Ossorio, L. / Burkowitz, J. / Nackunstz, I. / Brueggenjuergen, B. et al. | 2011
- A262
-
PSU15 the Economic Burden of Post-Transplant Events in Renal Transplant Patients in UK, Italy, Netherlands, Poland and BelgiumSennfalt, K. / Ling, C. / Pericleous, L. / Sbarigia, U. / Gatta, F. / Kolasa, K. / Zagorska, A. / Chamberlain, G. / Pandit, P. et al. | 2011
- A263
-
PSU21 Speech Problem and Health-Related Quality of Life in Head and Neck Cancer Survivors After Five Years of TreatmentsPayakachat, N. / Suen, J. Y. et al. | 2011
- A264
-
PSU26 Two-Year Changes in Generic and Obesity-Specific Quality of Life After Gastric BypassMar, J. / Arrospide, A. / Mar, B. / Martinez de Aragó / n, G. / Karlsson, J. et al. | 2011
- A265
-
PIN3 Comparing the Efficacy and Tolerability of Anti-Retroviral Therapy in Treatment-Naïve HIV-1 Infected Adults: A Systematic review of Randomized Clinical Trials and Bayesian Mixed Treatment Comparisons Including Atazanavir/R, Darunavir/R, Lopinavir/R, and EfavirenzVerheggen, B. / Vandeloise, E. / Treur, M. / Thuresson, P. O. / Lescrauwaet, B. et al. | 2011
- A266
-
PIN8 A Decision Tree Model Comparing Clinical Outcomes of Treatment with Telbivudine with or without “Tenofovir Add-on as Needed” and Lamivudine with or without “Tenofovir Add-on as Needed” in the Treatment of Chronic Hepatitis B Infection in TurkeyOzdemir, O. / Saylan, M. / Pakel, H. / Lescrauwaet, B. et al. | 2011
- A267
-
PIN13 Epidemiology of Staphylococcus Aureus Infections in Children: A Literature Review of the Last 10 YearsBricout, H. / Maier, W. / Mouchet, J. et al. | 2011
- A268
-
PIN18 Budget Impact Analysis of Tenofovir in Treatment of Chronic Hepatitis B (CHB)Gwiosda, B. / Krzystek, J. / Rys, P. / Wladysiuk, M. / Mierzejewski, P. / Kazmierski, M. / Plisko, R. et al. | 2011
- A269
-
PIN24 Potential Costs Associated with New Direct Acting Antiviral (DAAs) Therapy for Untreated Chronic Hepatitis C Genotype 1 Infection in the Veterans Health AdministrationChan, K. / Lai, M. N. / Groessl, E. J. / Hanchate, A. / Hernandez, L. / Wong, J. B. / Clark, J. A. / Asch, S. / Gifford, A. L. / Ho, S. et al. | 2011
- A270
-
PIN31 Quantifying the Financial and Disease Burden Associated with Mother to Child Transmission of HIV in UgandaKuznik, A. / Semeere, A. / Sempa, J. / Auerbach, B. / Lamorde, M. / Castelnuovo, B. / Hermans, S. / Ssewankambo, F. / Ssennono, M. / Mpanga Sebuyira, L. et al. | 2011
- A271
-
PIN36 Surgical Site Infection Incidence and Burden Assessment Using Multi-Institutional Real-World DataDelissovoy, G. / Pan, F. / Patkar, A. D. / Edmiston, C. E. / Peng, S. et al. | 2011
- A272
-
PIN41 Cost-Benefit Analysis of Regional Procured Essential Medicines in the Southern African Development Community (SADC) with a Focus on Access to Antiretroviral DrugsMiller-Jansö / n, H. E. / Stander, M. et al. | 2011
- A274
-
PIN53 Cost-Effectiveness Analysis of Pegylated Interferon Alpha-2A Versus Pegylated Interferon Alpha-2B in the Treatment of Chronic Hepatitis C Patients in PolandMacioch, T. / Paweska, J. / Niewada, M. / Berak, H. / Szkultecka-Debek, M. / Russel-Szymczyk, M. et al. | 2011
- A275
-
PIN58 Cost-Effectiveness Analysis of Pneumococcal 13-Valente Conjugate Vaccine Versus Pneumococcal 10-Valente Conjugate Vaccine in the Pediatric Immunization Routine, from the São Paulo State Public Health Care System (Brazil)Pepe, C. / Teich, V. / Mould, J. F. et al. | 2011
- A276
-
PIN63 Cost-Effectiveness Analysis of Anti-Pneumococcal Vaccines in PanamaLutz, M. A. / Luciani, K. / Morales, G. / Strutton, D. R. / Roberts, C. S. / Farkouh, R. A. / Cuesta, G. et al. | 2011
- A277
-
PIN68 Cost- Effectiveness Analysis of Human Papillomavirus Vaccination Program in RussiaOmelyanovsky, V. / Avxentyeva, M. / Krysanov, I. / Ivakhnenko, O. / Goryaynov, S. / Tsfasman, F. M. et al. | 2011
- A278
-
PIN73 Modeling the Long Term Clinical Outcomes and Health Care Cost Impact of Initiating Treatment with Atazanavir/R Compared with Darunavir/R, Lopinavir/R and Efavirenz for HIV-1 Infected Treatment-NaÏve Patients: Country Results for Italy, Spain, Portugal and UKThuresson, P. O. / Verheggen, B. / Heeg, B. / Aldir, I. / Carrasco, J. / Didoni, G. / Mesa, O. A. / Lescrauwaet, B. et al. | 2011
- A279
-
PIN78 Cost Utility of Infant Vaccination Against Respiratory Syncytial Virus Infection in the NetherlandsMeijboom, M. / Rozenbaum, M. / Benedictus, A. / Luytjes, W. / Kneyber, M. / Wilschut, J. / Hak, E. / Postma, M. et al. | 2011
- A280
-
PIN83 Cost-Effectiveness and Cost-Utility analysis of 200 Days Prophylaxis of Cytomegalovirus (CMV) infections in High Risk (D+/R-) Kidney Transplant Recipients in PolandKawalec, P. / Holko, P. / Boratynska, M. / Glyda, M. / Ignacak, E. / Russel-Szymczyk, M. / Szkultecka-Sebek, M. / Kaweczynska-Lason, A. et al. | 2011
- A282
-
PIN94 Assessment of Health Related Quality of Life (HRQOL) in Hepatitis- B PatientsHaq, N. / Shafie, A. A. / Hassali, M. A. / Ibrahim, M. I. / Saleem, F. et al. | 2011
- A283
-
PIN99 Modelling the Impact of Extended Vaccination Strategies on the Epidemiology of PertussisRozenbaum, M. H. / De vries, R. / Postma, M. J. / Le, H. H. et al. | 2011
- A284
-
PIN105 Financial Support for HIV/AIDS Prevention, Care and Treatment in ThailandLayton, M. R. / Pachanee, K. / Prakongsai, P. et al. | 2011
- A285
-
PIN110 Development of A Large Safety Database Using Studies Conducted During the Clinical Development and Post-Marketing of A Virosomal Aluminium-Free Hepatitis A VaccineFaure, C. / Koller, A. / Hartmann, K. / Chré / tin, S. / Doux, S. / Visè / le, N. / Bugnard, F. / Maier, W. et al. | 2011
- A286
-
PMH2 The Efficacy of the New Antidepressant Agomelatine as Compared Against Placebo and SSRIS: A Meta-Analysis Combining Published and Unpublished DataBallesteros, J. / Tarapues, M. / Santos, B. / Rueda, J. R. et al. | 2011
- A287
-
PMH7 Aasenapine Versus Other Antipsychotics in Bipolar I Disorder: Indirect Comparisons at Twelve WeeksSapin, C. / Corson, H. / Beillat, M. / Hansen, K. et al. | 2011
- A288
-
PMH12 Risk of Relapse and Hospitalization in the 2-Year Open-Label Treatment of Outpatients with Schizophrenia Randomized to Olanzapine Long-Acting Injection or Oral OlanzapineNovick, D. / Ascher-Svanum, H. / Bertsch, J. / Detke, H. / Mcdonnell, D. / Witte, M. / Haro, J. et al. | 2011
- A289
-
PMH17 The Economic and Social Consequences of Schizophrenia Treatment with Seroquel XR® (Quetiapine Prolonged Release Tablets) in Poland: Aanalysis of the Impact on the Health Care SystemFaluta, T. / Rdzanek, M. / Pierzgalska, K. / Wró / bel, B. et al. | 2011
- A290
-
PMH23 The Economic Burden of Mental Ill Health in the Workplace: A Costing Approach for Brazilian EmployersReis, T. C. / Takemoto, M. M. / Takemoto, M. L. / Fernandes, R. A. / Tolentino, A. C. / Cukier, F. N. / Santos, P. M. / Cruz, R. B. / Ribeiro, A. C. / Fernandes, R. R. et al. | 2011
- A291
-
PMH29 Cost Effectiveness of Extended Release Quetiapine Fumarate (Quetiapine XR) Monotherapy in Turkey in Patients with Major Depressive Disorder (Mdd) Who Have Failed Previous Antidepressant TherapyAydemir, O. / Dilbaz, N. / Malhan, S. et al. | 2011
- A292
-
PMH35 A Cost-Effectiveness Analysis of Paliperidone Palmitate Versus Olanzapine Pamoate in the Treatment of Schizophrenia in NorwayEinarson, T. R. / Vicente, C. / Zilbershtein, R. / Piwko, C. et al. | 2011
- A293
-
PMH40 Economic Evaluation of Agomelatine for Major Depressive Disorder in AustraliaO'Leary, B. A. / Hamann, G. B. / Adena, M. A. et al. | 2011
- A294
-
PMH46 The Quality of Life of Children With ADHD and their Parents: Results of EQ-5D and Kidscreen-10Van Der Kolk, A. / Bouwmans, C. / Schawo, S. / Buitelaar, J. B. / van der Gaag, R. J. / Van agthoven, M. / Hakkaart-van Roijen, L. et al. | 2011
- A295
-
PMH51 Measuring Relapse After Substance Abuse Treatment: A Proportional Hazard ApproachCiesla, J. / Mazurek, K. et al. | 2011
- A296
-
PMH56 Negative Symptoms Have Greater Impact on Functioning Than Positive Symptoms in Schizophrenia: Analysis of Catie DataRabinowitz, J. / Garibaldi, G. / Levine, S. / Bugarski-Kirola, D. / Berardo, C. / Kapur, S. et al. | 2011
- A297
-
PMH61 A Descriptive Analysis of Atomoxetine Utilization in Attention Deficit/Hyperactivity Disorder (ADHD) the United Kingdom and ItalySikirica, V. / Mitra, D. / Fridman, M. / Davis, K. L. / Hodgkins, P. et al. | 2011
- A298
-
PMH66 12-Year Trend Analysis on the Characteristics, Primary Payer, and Prescribed Medications of Physician-Office Visits for Patients with Dementia in the United StatesChen, Y. J. / Sankaranarayanan, J. / Murman, D. L. et al. | 2011
- A300
-
PMH77 Prescription Pattern Evaluation for Bipolar Disorder in a Treatment Facility in IndiaNagappa, A. N. / Kumar, M. / Noorunnisa, S. / Bhandary, P. V. / Veerupaksh, D. / Balakrishnan, R. et al. | 2011
- A301
-
PMH83 Estimating Utilities in Schizophrenic and Bipolar Patients from Disease-Specific or Generic Instruments Assessing Patients' Health States: Where are the Differences?Cuervo, J. / Rebollo, P. / Maurino, J. / Cordero, L. / Castejó / n, N. et al. | 2011
- A303
-
PMS10 Evaluation the Risk Factors of Second Hip Fractures in the ElderlySebestyé / n, A. / Sá / ndor, J. / Patzai, B. / Gõ / cze, K. / Kriszbacher, I. / Mintá / l, T. et al. | 2011
- A304
-
PMS15 Costs of Tumor Necrosis Factor Blockers per Treated Patient Across Adult Indications Using Real-World Data in US Commercially-Insured PopulationSchabert, V. / Gandra, S. R. / Watson, C. / Fox, K. M. / Yeaw, J. / Goodman, S. / Milev, S. / Harrison, D. J. et al. | 2011
- A305
-
PMS20 Treatment of Patients with Moderate and Severe Psoriasis – Cost-of-Illness in the Czech RepublicPetrikova, A. / Klimes, J. / Dolezal, T. / Marinov, L. / Petrova, G. et al. | 2011
- A307
-
PMS31 Cost-Effectiveness of Abatacept for the Treatment of Rheumatoid Arthritis (RA) After the Failure of a First TNF inhibitor in the United KingdomPericleous, L. / Lebmeier, M. et al. | 2011
- A308
-
PMS36 Economic Analysis of Etanercept in Rheumatoid Arthritis from a Public perspective in ColombiaFernandes, R. A. / Tovar, D. A. / Mould, J. F. et al. | 2011
- A309
-
PMS41 Assessing the Cost Effectiveness of Broadening Access to Alendronate for the Prevention of Osteoporotic Fracture in AustraliaTilden, D. / Jackson, D. / Tay-Teo, K. / Van Bavel, J. et al. | 2011
- A310
-
PMS46 Cost-Utility Analysis of Certolizumab Pegol versus Alternative Tumor Necrosis Factor-Inhibitors, for the Treatment of Moderate-to-Severe Rheumatoid Arthritis in SpainVilloro, R. / Hidalgo, A. / Ferro, B. / Talavera, P. et al. | 2011
- A311
-
PMS51 A Cost Utility Analysis of Anti-TNF Agents for the Treatment of Rheumatoid ArthritisAdams, R. C. / Walsh, C. / Schmitz, S. / Barton, P. / Barry, M. et al. | 2011
- A312
-
PMS56 Subjective Health Expectations of Rheumatoid Arthritis Patients Starting Biological TherapyGulacsi, L. / Brodszky, V. / Baji, P. / Gulacsi, L. x. / Pé / ntek, M. et al. | 2011
- A314
-
PMS67 Determining the True Impact of Dupuytren'S Disease: A Qualitative StudyWilburn, J. / McKenna, S. / Crawford, S. R. / Perry-Hinsley, D. / Bayat, A. et al. | 2011
- A315
-
PMS72 Assessment of Prior Use of Prescribed Pain Medications Among Elderly Patients Who Initiated DuloxetineChen, S. Y. / Peng, X. / Wu, N. / Bernauer, M. / Rao, P. / Boulanger, L. / Zhao, Y. et al. | 2011
- A316
-
PMS77 Improving Quality and Reducing Costs in Workers' Compensation Health Care: A Population-Based Intervention StudyWickizer, T. M. / Franklin, G. M. / Fulton-Kehoe, D. et al. | 2011
- A317
-
PND3 Risk-Benefit Analysis of Therapy in Multiple SclerosisQizilbash, N. / Mé / ndez, I. / Sá / nchez-de la Rosa, R. et al. | 2011
- A318
-
PND9 The Role of Spontaneous Events Databases for Benefit-Risk AnalysisQizilbash, N. / Mé / ndez, I. / Sá / nchez-de la Rosa, R. et al. | 2011
- A319
-
PND14 Comparing Expected Costs associated with Three Screening Strategies for Cystic Fibrosis Along SpainRamos-Goñ / i, J. M. / Valcá / rcel-Nazco, C. / Castilla-Rodrí / guez, I. / Espada-Sá / enz-Torre, M. / Tellerí / a-Orriols, J. J. et al. | 2011
- A320
-
PND20 A Cost-of-Illness Analysis Of Amyotrophic Lateral Sclerosis In GreeceAthanasakis, K. / Sideris, M. / Zacharis, M. / Rentzos, M. / Evdokimidis, I. / Kyriopoulos, J. et al. | 2011
- A321
-
PND25 Use of Drug Reimbursement as Markers of Disease for Epidemiological and Direct Cost analysis: The Case of Epilepsy in FranceFagnani, F. / Kusnik-Joinville, O. / de Zé / licourt, M. / Levy-Bachelot, L. / Branchoux, S. / Murat, C. / Bertrand, M. / Kahane, P. et al. | 2011
- A322
-
PND31 A Modelled Economic Evaluation of Firazyr® (Icatibant) for Symptomatic Treatment of Acute Attacks of Hereditary Angioedema (HAE) in Adults with C1-Esterase-Inhibitor (C1-INH) DeficiencyTilden, D. / Cottrell, S. / Tocchini, L. / Jayaram, N. / Sinani, R. / Barnes, D. et al. | 2011
- A323
-
PND36 Factors Associated with Utility and Disutility Values in Relapsing Form of Multiple Sclerosis (RMS) Patients Using Data from Temso, A Teriflunomide Pivotal Phase III TrialO' / Connor, P. / Briggs, A. / Carita, P. / Bego-Le-Bagousse, G. et al. | 2011
- A324
-
PND41 Predicting EQ-5D Utility Scores from the Huntington quality of Life instrument (H-QOL-I)Clay, E. / Briquet, B. / Aballea, S. / Maman, K. / Toumi, M. et al. | 2011
- A325
-
PND46 The Huntington Quality of Life Instrument (H-QOL-I): Cross-Cultural Validation in Germany, Poland and USAClay, E. / Mraidi, M. / Zielonka, D. / Cohen, J. / Toumi, M. / Auquier, P. et al. | 2011
- A326
-
PND51 The Relationship Between Patient-Reported Health-Related Quality of Life and Disability Status Among Patients with Multiple SclerosisKhalaf, K. M. / Globe, D. / Armstrong, E. / Malone, D. / Coyne, K. et al. | 2011
- A327
-
PND56 Quality of Life Assessments in Adults with Attention Deficit/Hyperactivity Disorder - A Systematic ReviewMarfatia, S. / Shroff, K. / Munshi, S. / Tiwari, A. et al. | 2011
- A328
-
PND61 Impact of Patient Cost-Sharing Arrangements for Disease Modifying Therapies on Treatment Compliance among Patients with Multiple Sclerosis in the United StatesPalmer, L. A. / Fowler, R. / Shi, N. / Dastani, H. / Abouzaid, S. / Kim, E. et al. | 2011
- A329
-
PND66 Cross-Cultural Adaptation and Validation of the Brazilian Version of the Fatigue Severity Scale (FSS)Toledo, F. O. / Junior, W. M. / Speciali, J. G. / Sobreira, C. F. et al. | 2011
- A330
-
PUK3 Sources of Heterogeneity Among Overactive Bladder Clinical Trial Estimates of Tolterodine and Fesoterodine Reductions of Urgency Urinary Incontinence Episodes Relative to PlaceboSnedecor, S. J. et al. | 2011
- A331
-
PUK9 Comparative Cost Analysis of Treatment for Renal Anemia with Methoxy Polyethylene-Glycol Erythropoietin Beta (MIRCERA®) Versus Erythropoietin Beta (NEORECORMON®)Medina Gó / mez, J. L. et al. | 2011
- A332
-
PUK14 Trends in Rate and Cost of Hospitalizations Due to Chronic Kidney Disease (CKD) in the United StatesAggarwal, S. et al. | 2011
- A333
-
PHP3 Patient Preferences Considering the Choice of Health Care Providers in Hungary – Results From Discrete Choice ExperimentBaji, P. / Pavlova, M. / Gulacsi, L. / Groot, W. et al. | 2011
- A334
-
PHP9 Temporary Use Authorizations: The Economic and Clinical Future of Drugs Used in the French Compassionate ProgramDegrassat-Thé / as, A. / Paubel, P. / Parent de Curzon, O. / Le Pen, C. / Sinè / gre, M. et al. | 2011
- A335
-
PHP14 Multiple Indication Pricing, Reimbursement and Funding Dynamics: The Case of Orphan IndicationsWild, L. / Forster, L. et al. | 2011
- A336
-
PHP21 Adoption of New Medicines in the OECD: Regulation, Innovation and ScaleVarol, N. / Costa-i-Font, J. / Mcguire, A. J. et al. | 2011
- A337
-
PHP26 Health Outcomes and Economics Research for Regenerative Medicine and Cellular Therapies: Lessons From A Multi-Market Health Technology Assessment and Reimbursement reviewFaulkner, E. C. / Fernandez, M. / Spinner, D. S. et al. | 2011
- A338
-
PHP31 The Economic Impact of Switches of Prescription Drugs to the Over-the-Counter Status (Rx-to-OTC): A Systematic Literature ReviewKarray, S. M. / Plich, A. / Flostrand, S. / Toumi, M. et al. | 2011
- A339
-
PHP37 Regional Drug Evaluation in Spain: A Comparison Among CommitteesHerná / ndez-Pastor, L. J. / Huerta, A. et al. | 2011
- A340
-
PHP42 Drug Consumption in Bosnia and Herzegovina - Comparison to Neighboring CountryKrehic, J. / Gavrankapetanovic, F. / Djapo, M. / Agic, N. et al. | 2011
- A341
-
PHP48 Croatian Pharmaceutical Expenditure Before and After Healthcare Reform – Comparison to EU CountriesPogorilic, S. / Vitezica, P. / Bolanca, S. et al. | 2011
- A342
-
PHP54 Predictors of Avoidable Emergency Room Visits Among High Cost Medicaid EnrolleesGanduglia, C. / Franzini, L. / Dunn, K. et al. | 2011
- A343
-
PHP59 Estimation of Increases in Direct Medical Expenditures Associated with Medication Nonadherence and Potential Savings from Increased AdherenceHicks, K. A. / Karve, S. J. / Vlahiotis, A. / Frazee, S. G. / Tian, Y. / Earnshaw, S. R. et al. | 2011
- A344
-
PHP64 Reorganisation of Hospital Emergency Services: A Business Case for Quality ImprovementEichler, K. / Senn, O. / Rü / themann, I. / Bö / gli, K. / Sidler, P. / Brü / gger, U. et al. | 2011
- A345
-
PHP70 Value Based Pricing (VBP): Is This the Way Forward for the UK NHS?Comberiati, U. / Dass, R. N. / White, N. et al. | 2011
- A346
-
PHP75 The Cost Per Day of Intensive Care Units (ICU) in France: The CRRÉA StudyGarrigues, B. / Lefrant, J. Y. / Bazin, J. / Bardoulat, I. / Tagdichti, K. / Courtial, F. / Maurel, F. / Pribil, C. et al. | 2011
- A347
-
PHP80 Where A Cheap Medicine is Not the Same as A Generic Medicine: The Belgian CaseDylst, P. / Vulto, A. / Simoens, S. et al. | 2011
- A348
-
PHP86 Incorporating the Patient Perspective Into the Health Care Process: Experience from the C.A.T. Health SystemRebollo, P. / Castejó / n, N. / Cuervo, J. / Igarreta, M. / Ortega, F. et al. | 2011
- A349
-
PHP92 Lack of Clinical Efficacy as a Main Reason for Ahtapol Negative Recommendations for Orphan Oncology DrugsOfierska-Sujkowska, G. / Jagodzinska-Kalinowska, K. / Matusewicz, W. / Pasierski, T. et al. | 2011
- A350
-
PHP97 Use of Paediatric “Observation Status” and Effect on in-Patient Admission Rate in Accident and Emergency (A&E) DepartmentsLaokri, S. / Zhang, W. H. / Ben Hamed, N. / Cohen, L. / De Wever, A. / Alexander, S. et al. | 2011
- A351
-
PHP103 Global Health Care Reforms and Pricing, Access and Health Outcomes StrategyAggarwal, S. et al. | 2011
- A352
-
PHP108 Public Health and Prevention in Europe: Is it Cost-Effective?Simoens, S. et al. | 2011
- A353
-
PHP113 Measuring the Organizational Performance in Tennessee: A Case of Community HospitalsRoh, C. Y. / Shirore, R. M. et al. | 2011
- A354
-
PHP119 Is There No Optimal Approach for Orphan Drugs to Patient Access? Rare Disease is Not Rare and Needs to Develop the New Pricing and Reimbursement SolutionKim, S. / Cho, Y. / Shim, S. / Lee, J. / Kim, W. / Bae, K. et al. | 2011
- A355
-
PHP124 Personalized Decision Making in Cancer Medicine? Systematic Overview of HTA Procedures and Specific Approaches in Ten Countries Across Four ContinentsSchwarzer, R. / Rochau, U. / Mü / hlberger, N. / Jahn, B. / Sroczynski, G. / Schnell-Inderst, P. / Schall, I. / Kallinger, S. / Lackner, M. et al. | 2011
- A356
-
PHP129 Societal Preferences for Health Technology Disinvestment Policy: Views of Scottish Taxpayers – A Qualitative StudyHislop, J. M. et al. | 2011
- A357
-
PHP134 Comparison of the Knowledge in Standard Treatment Guidelines among Medical Practitioners and Medical StudentsHettihewa, L. M. / Wimalasena, G. / Tharanga, D. et al. | 2011
- A359
-
PHP146 Current Status and Trends in Performance-Based Schemes Between Health Care Payers and ManufacturersCarlson, J. J. / Gries, K. / Sullivan, S. D. / Garrison, L. et al. | 2011
- A360
-
PHP151 Evidence on the Impact of Managed Entries on Payers, Patients, Manufacturers, and Health Care WorkersFerrario, A. / Nicod, E. / Kanavos, P. et al. | 2011
- A361
-
PHP157 Using the CEAC for Value Based Pricing: Don'T Change the GoalpostsRoberts, G. et al. | 2011
- A363
-
PHP168 Endogenous Cost-Effectiveness Analysis in Health Care Technology AdoptionJena, A. B. / Philipson, T. J. et al. | 2011
- A364
-
PCV5 Thromboembolisms with Thrombopoietin Receptor Agonists: Systematic Review and Meta-Analysis of Randomized Controlled TrialsCorrales-Á / lvarez, I. / Catalá / pez, F. / Martí / n-Serrano, G. / Montero-Corominas, D. / Calvo-rojas, G. et al. | 2011
- A366
-
PCV15 Guidelines Adherence and Hypertension Control in Patients Suffering from Cardiovascular DiseaseAhmad, N. / Hassan, Y. / Tangiisuran, B. / Meng, O. L. / Aziz, N. A. / Saleem, F. / Atif, M. et al. | 2011
- A367
-
PCV19 Prescription of Angiotensin Converting Enzyme Inhibitors and Hypertension Control in Diabetic Hypertensive PatientsAhmad, N. / Hassan, Y. / Tangiisuran, B. / Meng, O. L. / Aziz, N. A. / Saleem, F. / Atif, M. et al. | 2011
- A368
-
PCV25 Characterising Patients with A First-Time Admission for atrial Fibrillation in the United KingdomJones, J. / Townsend, R. / Jameson, K. / Amber, V. / Evans, L. M. et al. | 2011
- A370
-
PCV37 Parametric Conditional Non-Frailty Model for Recurrent Events in Persons with Type 2 Diabetes in Sweden: The Example of Myocardial InfarctionAhmad Kiadaliri, A. / Clarke, P. M. / Gerdtham, U. G. / Nilsson, P. / Eliasson, B. / Gudbjö / rnsdottir, S. / Steen carlsson, K. et al. | 2011
- A371
-
PCV42 A Budget Impact analysis to Estimate the Economic Impact of Sevikarhct® for the Treatment of Arterial Hypertension in SpainDarba, J. / Kaskens, L. / Nilsson, J. / Oberdiek, A. et al. | 2011
- A372
-
PCV47 Analysis of Transient Ischemic Attack-Related Clinical Outcomes, Health Care Utilization and Cost Burden of Patients with Non-Valvular Atrial FibrillationBaser, O. / Wang, L. et al. | 2011
- A373
-
PCV53 Cost Study of Caregiving for Patients with Chronic Symptomatic Heart Failure in Spain, Insights from the Inoescaro StudyMarti, B. / Delgado, J. / Oliva, J. / Llano, M. / Pascual, P. / Comin, J. / Grillo, J. J. / Diaz molina, B. / Culebras, J. / Martí et al. | 2011
- A376
-
PCV70 Cost Effectiveness of Ticagrelor in the Treatment of Acute Coronary Syndrome in GermanyTheidel, U. / Asseburg, C. / Giannitsis, E. / Katus, H. et al. | 2011
- A377
-
PCV76 A Cost-Effectiveness Analysis of Clopidogrel in Patients with Non Stable Acute Coronary Syndrome in GreeceKourlaba, G. / Fragoulakis, V. / Maniadakis, N. et al. | 2011
- A378
-
PCV81 Cost-Effectiveness of Ticagrelor Versus Clopidogrel in Patients with Acute Coronary Syndrome: Results from the Plato Study: A Canadian AnalysisMittmann, N. / Chan, B. / Seung, S. J. / Liovas, A. / Cohen, E. et al. | 2011
- A379
-
PCV86 Long-Term Cost-Effectiveness Analysis of Ticagrelor in Patients with Acute Coronary Syndrome (ACS) from A Mexican Public and Private Health Care Perspective Based on Data from the Plato TrialGarcia-Castillo, A. / De-los-Rios, M. / Polanco, A. C. / Ramirez, M. A. / Nikolic, E. / Mellströ / m, C. et al. | 2011
- A380
-
PCV91 Cost-Effectiveness of Endovascular Treatment Versus Open Surgery in Patients with Steno-Occlusive Disease of the Femoral ArteryRamos-Goñ / i, J. M. / Mar-Medina, J. / Valcá / rcel-Nazco, C. / Castilla-Rodrí / guez, I. et al. | 2011
- A382
-
PCV102 Evaluation of the Measurement Properties of the Antihypertensive Adherence SurveyHudgens, S. / Lynch, J. / Pasquale, K. / Zacker, C. et al. | 2011
- A383
-
PCV107 Correlation of Physician-Rated Adherence with Therapeutical Outcomes in Antihypertensive Treatment: Pooled Analysis Findings from Six Valsartan Studies Including 15,583 Available PatientsVilla, L. / Abraham, I. / Macdonald, K. / Denhaerynck, K. et al. | 2011
- A384
-
PCV112 A Comparison of European Health Care Systems on Stroke Prevention in Atrial Fibrillation – Interim Results of a Patient Satisfaction SurveyOberdiek, A. / Sandberg, A. / Franczok, E. et al. | 2011
- A386
-
PCV123 The Participation Decision for Lifestyle Disease ScreeningSø / gaard, R. / Lindholt, J. / Gyrd-Hansen, D. et al. | 2011
- A387
-
PCV128 A Real World Evaluation to Describe the Characteristics, Outcomes and Resource Use Associated with Patients Being Managed by a Secondary Care Based Anticoagulation ServiceRose, P. / James, R. / Chapman, O. / Marshall, S. et al. | 2011
- A388
-
PCV134 Concomitant Medciation Use in US Adults on Statin Therapy: Findings from a Multi-Employer Claims DatabaseMolife, C. / Zhu, Y. / Yu, C. / Mccracken, R. / Zhao, Z. et al. | 2011
- A389
-
PCV139 Epidemiology and Economic Burden of Atrial Fibrilation to the Public Health Care System in BrazilNasciben, V. / Piegas, L. S. / Figueiredo, M. J. / Martins, S. C. et al. | 2011
- A391
-
PGI2 The Relationship Between Acute and Chronic Acetaminophen Exposure and Liver ToxicityGokhale, M. N. / Foster, H. R. / Cleves, M. / Hogan, W. R. / James, L. P. / Martin, B. et al. | 2011
- A392
-
PGI7 Impact of Complications from Dysphagia on Hospital Charges in the United StatesJensen, I. S. / Helm, T. / Cyr, P. L. et al. | 2011
- A393
-
PGI13 Evaluation of the Clinical and Economic Burden of Chronic Constipation in BelgiumLeeuwenkamp, O. / Chevalier, P. / Lamotte, M. et al. | 2011
- A394
-
PGI18 Treatment of Chronic Hepatitis C Patients with Peginterferon Alfa-2a or Peginterferon Alfa-2b: A Cost-Effectiveness Analysis for the Portuguese NHS SettingAreias, J. / Branco, T. / Calinas, F. / Carvalho, A. / Macedo, G. / Manata, M. J. / Matos, L. / Rodrigues, B. / Velosa, J. / Pereira, C. et al. | 2011
- A395
-
PGI23 Economic Impact of Medication Adherence and Persistence in the Treatment of Ulcerative Colitis in Canada: Analyses with the Ramq DatabaseLachaine, J. / Yen, L. / Beauchemin, C. / Hodgkins, P. et al. | 2011
- A396
-
PGI28 Disease-Specific Health-related Quality of Life in Patients with Quiescent Ulcerative Colitis: Effects of one Year Maintenance Treatment with MMX MesalamineSolomon, D. / Yarlas, A. / Yen, L. / Hodgkins, P. / Karlstadt, R. / Kane, S. V. et al. | 2011
- A397
-
PGI33 Predictors of Direct Medical Costs of Crohn'S Disease and Ulcerative ColitisStark, R. G. / Hunger, M. F. / Reitmeir, P. / Kö / nig, H. H. / Leidl, R. et al. | 2011
- A398
-
PIH5 Respiratory Syncytial Virus (RSV) Prophylaxis in Special PopulationsPaes, B. A. / Li, A. / Lanctot, K. L. / Mitchell, I. et al. | 2011
- A399
-
PIH12 Patients with BPH in France: Results at Six Months with Phytotherapy Versus Other TreatmentsPerrin, P. / Auges, M. / Rahhali, N. / Taieb, C. et al. | 2011
- A400
-
PIH18 Rotavirus Gastroenteritis in Vulnerable Children: A UK Case Control StudyPockett, R. D. / Campbell, D. / Adlard, N. E. / Rajoriya, F. / Carroll, S. M. et al. | 2011
- A401
-
PIH23 Cost-Effectiveness of Guanfacine Extended Release as an Adjunctive Therapy to a Psychostimulant Compared to Psychostimulant Monotherapy for the Treatment of Attention Deficit/Hyperactivity Disorder in Children and AdolescentsSikirica, V. / Erder, M. / Xie, J. / Macaulay, D. / Diener, M. / Hodgkins, P. / Wu, E. Q. et al. | 2011
- A402
-
PIH28 Economic Evaluation of Pneumococcal Conjugated Vaccines for ArgentinaEllis, A. / Lepetic, A. C. / Gomez, J. A. et al. | 2011
- A403
-
PIH34 Patient Reported Reasons for Medication Nonadherence: A SurveyLee, K. / Nixon, M. / Cascade, E. / Plummer, C. / Law, V. / Lee, M. et al. | 2011
- A405
-
PIH45 Burden of Herpes Zoster and Post-Herpetic Neuralgia: Findings from a Cross-Sectional Patient Reported Outcomes StudyCarroll, S. / Gater, A. / Abetz, L. / Demuth, D. / Smith, F. / Mannan, A. et al. | 2011
- A406
-
PIH50 quality of Life of Students from the Faculty of Pharmacy at Medical University of Warsaw in 2011Zawodnik, S. / Kiljan, A. / Hermanowski, T. / Golicki, D. et al. | 2011
- A408
-
PIH62 Comparative Pricing and Reimbursement Analysis in Four East European CountriesPeev, S. / Petrova, G. / Baran, A. / Petrikova, A. / Daneasa, D. et al. | 2011
- A409
-
PIH67 Successful Development of Annual and Long Term Prediction Models to Estimate Height Outcome following Growth Hormone (GH) Therapy in Children Using Data from KIGS – A Large Pharmacoepidemiological SurveyLoftus, J. / Ranke, M. / Lindberg, A. / Brosz, M. / Kaspers, S. / Wollmann, H. / Koltowska-Haggstrom, M. / Roelants, M. et al. | 2011
- A410
-
PSY4 Comparison of Infliximab and Ustekimumab for Treatment of Moderate to Severe Psoriasis: a Mixed Treatment Meta-AnalysisFan, T. / Bennett, H. / Smith, N. / Marin, M. / Sen, S. et al. | 2011
- A412
-
PSY15 Striving for Affordable Treatments Within the Greek Environment: Do Epoetin Biosimilars Help?Kani, C. / Litsa, P. / Alexopoulou, E. / Hatzikou, M. / Delibasi, S. / Geitona, M. et al. | 2011
- A413
-
PSY20 The Annual Direct Medical Cost of Systemic Lupus Erythematosus (Sle) Patients and Costs Drivers (Lucie Study): French ResultsAmoura, Z. / Pennaforte, J. L. / Hamidou, M. / Arfi, S. / Lazaro, E. / Hachulla, E. / Pourrat, J. / Queyrel, V. / Aubin, C. / Garofano, A. et al. | 2011
- A414
-
PSY25 What is the Economic Impact of Obesity on Hospital Inpatient Care?Pereira, J. / Ribeiro, V. / Mateus, C. et al. | 2011
- A415
-
PSY31 Cost-Effectiveness of Tapentadol Prolonged-Release (Pr) Compared to Oxycodone Controlled Release (Cr) in Patients with Chronic Severe Non-Cancer Pain in IrelandObradovic, M. / Ikenberg, R. / Hertel, N. / Liedgens, H. et al. | 2011
- A416
-
PSY36 Modelling the Cost-Effectiveness of Orlistat as a Treatment for Obesity in Primary CareAra, R. / Blake, L. et al. | 2011
- A417
-
PSY42 Chronic Pain: Patient Treatment Preferences - a Discrete Choice ExperimentMü / hlbacher, A. / Ezernieks, J. / Nü / bling, M. et al. | 2011
- A418
-
PSY47 Evaluating the Cross-over Effect on Health-related Quality of Life in a Randomized Cross-over Study of Hemophilia-A PatientsJo, H. / Gringeri, A. / Leissinger, C. / Mantovani, L. / Cortesi, P. / Gemmen, E. et al. | 2011
- A419
-
PSY53 Changes in Concomitant therapy for Weight-related Illness Following Initiation of Weight Loss PharmacotherapyAgatep, B. C. / Charland, S. L. / Herrera, V. / Hawk, G. / Stanek, E. J. et al. | 2011
- A420
-
PSY58 Responsiveness of the Treatment Satisfaction with Medicines Questionnaire (Satmed-Q) in a Longitudinal Sample of Patients with Neuropathic PainRejas, J. / Ruiz, M. A. / Pardo, A. / Ruiz, L. / Soto, J. et al. | 2011
- A421
-
PRM5 Novel Patient Reported Outcomes and Data Tool for Chronic Disease Management (PROCDIM): Case in Point Prostate CancerAggarwal, S. et al. | 2011
- A422
-
PRM11 Learning Effect in Economic Evaluations of Health Care InterventionsChang, S. / Sungher, D. / Diamantopoulos, A. et al. | 2011
- A423
-
PRM17 Suitability of CLAD-CQR Models for Obtaining QALYsCunillera, O. / Vilagut, G. / Medina, A. / Tresserra, R. / Alonso, J. / Brugulat, P. / Garcí / a, C. / Ferrer, M. et al. | 2011
- A424
-
PRM22 Microsimulation Methods Used for Health Policy Decisions in Personalized Medicine Under Constrained ResourcesJahn, B. / Rochau, U. / Mü / hlberger, N. / Sroczynski, G. / Conrads-Frank, A. / Siebert, U. et al. | 2011
- A425
-
PRM27 Modelling the Brazilian Extended Consumer Price Index for Pharmaceutical Products: Comparison Between Exponential Smoothing and Box-Jenkins MethodsSantos, P. M. / Takemoto, M. L. / Fernandes, R. A. / Tolentino, A. C. / Takemoto, M. M. / Fernandes, R. R. / Padula, A. C. / Cukier, F. N. / Cruz, R. B. et al. | 2011
- A426
-
PRM33 Systematic Review of Health State Utilities in SpainGarcí / a-Pé / rez, L. / Aguiar-Ibá / ez, R. / Linertová / R. / Rivero-Santana, A. / Abá / solo-Alessó et al. | 2011
- A428
-
PRM44 The First Research: Assessment of the WTP Threshold for QALY by Contingent Valuation Method in RussiaZelenova, O. et al. | 2011
- A429
-
PRM49 Evaluation of Bivariate Meta-analysis Methods to Synthesise Results of Several Studies with Two Correlated EndpointsAballea, S. / Vataire, A. L. / Neine, M. E. / Le coroller, G. / Toumi, M. et al. | 2011
- A430
-
PRM55 A New Approach to Modeling Cancer Recurrence and Follow-UpRose, J. / Augestad, K. M. / Cooper, G. / Meropol, N. J. et al. | 2011
- A431
-
PRM60 Assessing Relative Clinical Value Across Tumor Types in Metastatic DiseaseKarweit, J. / Nanavati, S. / Van Baardewijk, M. / Wagner, S. / Kotapati, S. et al. | 2011
- A432
-
PRM66 Comparison of Reconciliation and Review Methodologies for the Translation of Patient Reported Outcome (PRO) MeasuresVerjee-Lorenz, A. / Two, R. / Clayson, D. / Miller, F. et al. | 2011
- A433
-
PCN3 Cetuximab for the First-Line Treatment of Metastatic Colorectal CancerUbago, R. / Castillo, M. A. / Flores, S. / Rodriguez, R. / Beltran, C. et al. | 2011
- A434
-
PCN8 Incidence, Predictive Factors, and Infection Complications of Prolonged Neutropenia in R-CHOP/CHOP Treated Diffuse Large B-Cell Lymphoma PatientsZhou, K. R. / Kei, K. M. / Ng, H. M. / Wong, R. S. et al. | 2011
- A435
-
PCN12 Dasatinib or Imatinib in Newly Diagnosed Chronic Myeloid Leukemia Patientes in the Chronic Phase: Five-Years Follow-up Simulated CohortDarba, J. / Perez-Alvarez, N. / Kaskens, L. / Martin, P. et al. | 2011
- A437
-
PCN23 Survival Analyses Adjusted for Crossover in Relapsed Multiple Myeloma: Results of the Apex TrialPacou, M. / Gauthier, A. / Abrams, K. / Spencer, M. et al. | 2011
- A438
-
PCN29 Budgetary Impact of Adoption of Erlotinib for Lung Cancer in the Private Health Insurance Market in Brazil: A Real World Data AnalysisClark, O. / Clark, L. G. / Botrel, T. E. / Medina, P. / Paladini, L. / Rosa, B. / Rodrigues, N. / Fortes, A. F. / Castro, A. P. / Faleiros, E. et al. | 2011
- A439
-
PCN34 Cost Analysis of Anemia Treatment with Erythropoiesis-Stimulating Agents (ESAs) in Cancer Patients Receiving Chemotherapy in ItalyDuran, A. / Spaepen, E. / Lamotte, M. / Lucioni, C. / Kutikova, L. / Pujol, B. / Gozzo, M. / Annemans, L. et al. | 2011
- A440
-
PCN39 Burden of Brain Metastasis in an Metastatic Non-Small Cell Lung Cancer (NSCLC) PopulationGanguli, A. / Henk, H. / Teitelbaum, A. / Ray, S. et al. | 2011
- A442
-
PCN50 First and Second Line Lung Cancer Treatment Utilization Patterns and associated Costs in A United States Health Care Claims DatabaseRamsey, S. / Henk, H. / Sullivan, J. / Teitelbaum, A. / Akhras, K. / Sollano, J. / Smith, G. / Chen, C. et al. | 2011
- A443
-
PCN55 The Economic Burden of Adjuvant Chemotherapy in GermanyEiermann, W. / Rezai, M. / Kuemmel, S. / Kü / hn, T. / Benkow, A. / Hogberg, D. / Schweikert, B. / Blohmer, J. U. et al. | 2011
- A444
-
PCN60 Economic Evaluation of Vaccination Against Cervical Cancer in the Moscow RegionShakhanina, I. / Namazova-baranova, L. / Krasnopolskiy, V. I. / Zarochentseva, N. V. / Kozachenko, V. P. / Demarteau, N. / Shchurov, D. et al. | 2011
- A445
-
PCN65 Cost-Effectiveness of Treating Metastatic Renal Cell Carcinoma (mRCC) Patients Whose Disease Failed on one Prior VEGF-TKI Therapy with Everolimus Compared to Treating with Best Supportive Care (BSC) Alone in CanadaCasciano, R. / Chulikavit, M. / El Ouagari, K. / Wang, X. et al. | 2011
- A446
-
PCN70 Cost-Effectiveness of Cetuximab and Bevacizumab in the First-Line Treatment of Metastatic Colorectal Cancer (mCRC) for Patients with Kras Wild-Type Tumours in the United KingdomSamyshkin, Y. / Hertel, N. / Griebsch, I. et al. | 2011
- A447
-
PCN75 Epidemiologic and Economic Impact of HPV (6/11/16/18) Vaccination in TurkeyBakir, M. / Levent, A. / Nagy, L. / Brandtmü / ller, A. / Singhal, P. / Pillsbury, M. / Dasbach, E. et al. | 2011
- A448
-
PCN80 Comparative Analysis of Cost-Effectiveness Bevacizumab + Paclitaxel Versus Using Only Versus Paclitaxel as First Line Treatment of Patients with Metastatic Breast Cancer in Mexico Public Insurance (Seguro Popular)Arreola Ornelas, H. / Rosado Buzzo, A. / Garcí / a, L. / Camacho, L. M. / Lechuga, D. et al. | 2011
- A449
-
PCN86 Cost-Effectiveness of Rituximab in Follicular Lymphoma First Line Maintenance Treatment from Public Payer Perspective in PolandGadaj, A. / Kalinowska, A. / Hawrylecka, D. / Holojda, J. / Krawcewicz, A. / Spychalowicz, W. / Russel-Szymczyk, M. / Szkultecka-debek, M. et al. | 2011
- A450
-
PCN91 Pharmacoeconomic Analysis of mCRC Therapy With XELOX/FOLFOX4 Regimes With Bevacizumab or Cetuximab as the First Line Treatment in RussiaTikhomirova, A. V. / Yagudina, R. I. / Kulikov, A. U. et al. | 2011
- A452
-
PCN102 Economic Evaluation of Three Formulations of Leuprolide Acetate With Atrigel® in Androgen Deprivation Therapy for Advanced Prostate Cancer in Nine European CountriesRetsa, P. / Sidhu, M. / Odeyemi, I. / Tombal, B. / Wex, J. et al. | 2011
- A453
-
PCN107 Potential Benefits of Introducing A Companion Diagnostic in Advanced Non-Small Cell Lung CancerZaim, R. / Gaultney, J. / Redekop, W. / Uyl-de Groot, C. et al. | 2011
- A455
-
PCN117 Health Resource Utilisation (HRU) Associated with Skeletal-Related Events (SREs) in Patients with Bone Metastases (BMS): Results From a Retrospective, Multinational European StudyGunther, O. / Body, J. J. / Sleeboom, H. / Hechmati, G. / Pereira, J. / Maniadakis, N. / Terpos, E. / Acklin, Y. P. / Finek, J. / Mossman, T. et al. | 2011
- A456
-
PCN122 Disclosing Traditional & Complementary Medicines (T&CM) Use to the Health Care Providers: A Qualitative Study Among Cancer Patients at a Local Hospital in MalaysiaFarooqui, M. / Hassali, A. / Knight, A. / Akmal, A. / Tan, B. S. / Farooqui, M. A. et al. | 2011
- A457
-
PCN128 EQ-5D Utility Index in Patients with Metastatic Castration-Resistant Prostate Cancer (mCRPC) With Progression During or After First-Line Docetaxel TherapyJames, N. / Eisenberger, M. / Fizazi, K. / Heidenreich, A. / Joulain, F. / Laizet, C. et al. | 2011
- A458
-
PCN133 Measuring Patients' Expectation and Satisfaction With Integrative Cancer TherapyAn, S. M. / Kim, S. H. / Kim, K. S. / Chung, H. S. / Lee, S. K. / Cheon, S. / Lee, S. H. / Park, S. / Kim, E. H. / Eo, W. K. et al. | 2011
- A459
-
PCN138 The Impact of Advanced or Metastasic Non-Small Cell Lung Cancer (NSCLC) Symptoms on Patient Daily Living and Health Related Quality of Life: Final ResultsArtal, A. / Oramas, J. / Cobo, M. / Domine, M. / Barneto, I. / Rodrí / guez-Abreu, D. / Menendez-ureñ / a, M. / Andrade, J. et al. | 2011
- A461
-
PCN148 Estimating Quality of Life in Advanced Melanoma; A Comparison of Standard Gamble, SF-36 Mapped, and Eortc QLQ-C30 Mapped UtilitiesBatty, A. J. / Fisher, D. / Winn, B. / Wang, Q. / Tolley, K. / Rowen, D. et al. | 2011
- A462
-
PCN154 Discussing the Introduction of National Screening Programs in Greece: A Delphi StudySkroumpelos, A. / Pavi, E. / Kyriopoulos, J. et al. | 2011
- A463
-
PCN159 Diagnostics and Treatment of Patients with Non-Small-Cell Lung Cancer in Daily PracticeBlommestein, H. / Groen, H. / Smit, E. / Thunnissen, E. / Uyl-de Groot, C. et al. | 2011
- A464
-
PCN165 A First Estimate of the Incremental Impact of Males HPV Vaccination on HPV-Related Diseases in EuropeBresse, X. / Largeron, N. / Marty, R. / Roze, S. et al. | 2011
- A465
-
PCN171 Underlying Causes for Sub-Optimal Utilisation of Cancer Drugs Funds in EnglandViejo Viejo, I. / Kilby, S. et al. | 2011
- A466
-
PCN177 Assessment of Reimbursement Processes and Outcomes for Cancer Drugs in Croatia – Comparison to NICE and NCCN GuidelinesVitezic, D. / Vrdoljak, E. / Bolanca, S. et al. | 2011
- A467
-
PCN183 A Population-Based Registry for the Evaluation of New Treatment Options for Patients with Metastatic Renal Cell CarcinomaDe groot, S. / Redekop, W. / Kiemeney, L. / Uyl-de Groot, C. et al. | 2011
- A468
-
PCN188 Did Decision-Making Models from National Guidelines Change 1st Line Treatment Strategy for Patients with Metastatic Colorectal Cancer (MCRC)? The Results of Large Population Based Survey in Germany 2009Kellermann, L. / Hofheinz, R. D. / Arnold, D. et al. | 2011
- A469
-
PCN193 Using Whole Disease Modelling to Inform Economic Recommendations for the Detection, Diagnosis, Treatment and Follow-up of Colorectal CancerTappenden, P. / Brennan, A. / Chilcott, J. / Squires, H. et al. | 2011
- A471
-
PDB2 Considerably Increasing Incidence of Severe Hypoglycemia 2007-2010 Versus 1997-2000 – a German Longitudinal Population-Based StudyHolstein, A. / Patzer, O. M. / Machalke, K. / Holstein, J. D. / Dippel, F. W. / Kovacs, P. et al. | 2011
- A472
-
PDB8 A Network Meta Analysis to Compare Glycaemic Control in Patients with Type 2 Diabetes Treated with Exenatide Once Weekly or LiraglutideScott, D. / Boye, K. S. / Timlin, L. / Best, J. H. / Clark, J. et al. | 2011
- A473
-
PDB13 A Prospective Registry to Identify Patients' Characteristics Associated with Achieving Target Metabolic Control After Three Months Treatment with Insulin Glulisine in Type 1 And 2 Diabetes Mellitus Patients Previously Uncontrolled on Basal Insulin and/or Other Anti-Diabetic Treatment (API Registry)Gottesman, I. / Girard, M. / Shorey, S. et al. | 2011
- A474
-
PDB18 Australia: Management of the Diabetic Foot with Pedimed® Under Real Use ConditionsTaieb, C. / Auges, M. et al. | 2011
- A475
-
PDB24 Budget Impact Analysis of the Use of Aspart Insulin During Hospitalization of Patients with Hyperglycaemia in ItalyIannazzo, S. / Pradelli, L. / Montagnoli, R. / Militano, L. et al. | 2011
- A476
-
PDB29 Modeling the Impact of Enhanced Treatment of Type 2 Diabetes Mellitus in BulgariaBoyanov, M. / Petrova, G. / Henriksen, O. / Valov, V. et al. | 2011
- A477
-
PDB35 Estimating the Real Life Daily Usage and Daily Cost of GLP-1 Receptor Agonists in the UK SettingMcDonell, A. / Zammit, D. C. / Haslam, T. / Gregor, Z. / Wilson, B. P. et al. | 2011
- A478
-
PDB40 Economic Analysis of Diabetes Treatment Goals Defined by Polish Diabetes Association: How Much Does Cost-Effective Treatment Cost?Szmurlo, D. / Schubert, A. / Kostrzewska, K. / Rys, P. / Skrzekowska-Baran, I. et al. | 2011
- A479
-
PDB45 Cost-Effectiveness of Transferring Type 2 Diabetic Patients from Neutral Protamine Hagedorn (NPH) to Detemir in Portugal SettingsCarvalho, D. / Lindner, L. / Kozarzewski, M. et al. | 2011
- A480
-
PDB50 Reduction in Comorbidities and Cost Savings Associated with Biochemical Control in Patients with Cushing's Disease: A Literature-Based AnalysisPatel, D. / Stephens, J. M. / Wiegand, P. / Pulgar, S. et al. | 2011
- A482
-
PDB61 Assessment of Quality of Life in Children and Adolescents with Type 1 Diabetes MellitusMoreira, S. / Almeida, A. / Guerra, P. et al. | 2011
- A483
-
PDB66 Achievement of Glycemic Control and Relapse Among Patients Initiating Basal Insulin from a Geographically-Diverse Us Electronic Medical Record (EMR) DatabaseAargen, M. / Wu, N. / Boulanger, L. / Lamothe, K. et al. | 2011
- A484
-
PDB71 Cross-Sectional Analysis of Ambulatory Care Expenditure Among Patients with Type 2 Diabetes Mellitus (T2DM) According to Treatment Stage and Renal Function in France Using EGB Database (Echantillon Generaliste De Beneficiaires)Guelfucci, F. / Clay, E. / Aballea, S. / Toumi, M. / Lassalle, R. et al. | 2011
- A485
-
PDB77 Impact of Knowledge on Medication Adherence Among Type 2 Diabetes PatientsAl-Qazaz, H. K. / Syed Sulaiman, S. A. / Hassali, M. A. / Shafie, A. A. / Sundram, S. / Saleem, F. et al. | 2011
- A486
-
PDB82 Development of a Health Economic Model to Compare the Prevention, Treatment and Management Strategies of Type 2 DiabetesNagy, B. / Nagyjanosi, L. / Nagyistok, S. / Jó / zwiak-Hagymá / sy, J. / Dessewffy, Z. / Kalo, Z. / Vokó / Z. et al. | 2011
- A487
-
PRS4 Effectiveness Of a Multifactorial Intervention to Improve Adherence in Patients with Chronic Obstructive Pulmonary Disease (COPD) Icepoc StudyLeiva-Fernandez, F. / Barnestein-Fonseca, P. / Leiva- Fernandez, J. / Vidal-Españ / a, F. / Garcí / a-Ruiz, A. / Prados-Torres, D. et al. | 2011
- A488
-
PRS10 A Comparative Health Economic Evaluation of Two Treatments for Grass Pollen Induced Allergic RhinoconjunctivitisRonborg, S. M. / Svendsen, U. G. / Micheelsen, J. S. / Ytte, L. / Andreasen, J. N. / Ehlers, L. et al. | 2011
- A489
-
PRS15 Estimating the Budget Impact of Introducing Indacaterol in the Treatment of Chronic Obstructive Pulmonary Disease (COPD) from the Brazilian Public Health Care System (SUS) PerspectiveSuzuki, C. / Silva, N. L. et al. | 2011
- A490
-
PRS20 Costs of COPD By Disease Severity - a Comparison Over 10 YearsJansson, S. A. / Backman, H. / Lindberg, A. / Rö / nmark, E. / Lundbä / ck, B. et al. | 2011
- A492
-
PRS30 Identifying the Patient Population Where Treatment of Severe Allergic Asthma with Omalizumab (XOLAIR®) Exhibits Optimal Cost-Effectiveness in AustraliaTilden, D. / Cottrell, S. / Tocchini, L. / Frenzel, C. / Bonney, M. A. et al. | 2011
- A493
-
PRS36 The Cost-Effectiveness of Step Down from High Dose ICS/Laba Combination Therapy in Asthma in the UK SettingPaggiaro, P. / Buseghin, G. / Nicolini, G. / Patel, S. / Iannazzo, S. / Zaniolo, O. / Papi, A. et al. | 2011
- A494
-
PRS41 Cost-Effectiveness Analysis of Immunotherapy in Patients with Grass Pollen Allergic RhinitisWesterhout, K. Y. / Verheggen, B. G. / Schreder, C. H. / Sieber, J. / Augustin, M. et al. | 2011
- A495
-
PRS46 Effectiveness and Cost-Utility Estimates of Tiotropium Treatment and Pulmonary Rehabilitation Programs in French Patients with Chronic Obstructive Pulomonary DiseaseAtsou, K. / Hejblum, G. / Chouaid, C. et al. | 2011
- A496
-
PRS51 The Development of the Early Morning Symptoms of COPD Instrument (EMSCI)Palsgrove, A. / Houghton, K. / Hareendran, A. / Schaefer, M. / Setyawan, J. / Mocarski, M. / Carson, R. / Make, B. et al. | 2011
- A497
-
PRS56 Assessing Patient Report of Function: Content Validity of the Functional Performance Inventory-Short form (FPI-SF) in Patients with Chronic Obstructive Pulmonary DiseaseLeidy, N. / McCormack, J. / Hamilton, A. / Becker, K. et al. | 2011
- A498
-
PRS62 Comparison of Generic and Disease Specific Quality of Life Measures in Chronic Obstructive Pulmonary DiseaseAgh, T. / Inotai, A. / Meszaros, A. et al. | 2011
- A499
-
PRS67 Consumption Patterns and in Vitro Resistance of S. Pneumoniae to FluoroquinolonesSimoens, S. / Verhaegen, J. / Van Bleyenbergh, P. / Peetermans, W. / Decramer, M. et al. | 2011
- A500
-
PRS72 How Much Would the Universal Uptake of Gold Recommendations for Italian COPD Patients Cost?Zaniolo, O. / Bettoncelli, G. / Bosio, G. / Mantovani, L. G. / Pistelli, R. / Vaghi, A. / Villa, M. / Iannazzo, S. / Bamfi, F. / Pitrelli, A. et al. | 2011
- A501
-
PRS77 Application of Innovative Methods to Identify and Characterize Differential Responders in Clinical Trials of COPD: The Use of Mixture ModelsStull, D. E. / Houghton, K. / Gale, R. / Wiklund, I. / Capkun-Niggli, G. / Jones, P. et al. | 2011
- A502
-
PSS5 Visual Field Evolution in Glaucoma Patients Presenting With Different Disease Stages: Results From an Observational StudyGerlier, L. / Shlaen, R. / Wolfram, C. / Lamotte, M. / Verboven, Y. et al. | 2011
- A503
-
PSS11 Ranibizumab and Bevacizumab for the Treatment of Age-related Macular Degeneration: A Systematic Review and Economic EvaluationMartinez Ferez, I. M. / Flores Moreno, S. et al. | 2011
- A504
-
PSS16 Cost of Blindness in AustriaBrennig, C. / Schö / llbauer, V. / Walter, E. et al. | 2011
- A505
-
PSS22 A Cost-Effectiveness Analysis of Off-Label Biologics to Treat Sarcoid Posterior Uveitis Versus Standard of Care: Comparing Infliximab to Methotrexate and Systemic SteroidsPadula, W. V. / Yilmaz, T. / Cordero-Coma, M. et al. | 2011
- A506
-
PSS27 We Treat Eyes, Not People: The Systematic Overestimations of Utility in Age-Related Macular Degeneration ModelsVisser, M. S. / Amarakoon, S. / Missotten, T. / Busschbach, J. et al. | 2011
- A507
-
PSS32 Impact of Dry Eye on Everyday Life (Ideel) - Symptom Bother: Estimating Cut-off Scores for Dry Eye Severity GroupsAcaster, S. / Verboven, Y. / Begley, C. / Chalmers, R. / Abetz, L. / Thompson, T. et al. | 2011
- A508
-
PSS37 the Clinical and Economic Burden of Acute Otitis Media: A Large Prospective Observational Cohort Study in EuropeLiese, J. G. / Giaquinto, C. / Silfverdal, S. A. / Carmona, A. / Larcombe, J. / Garcia-Sicilia, J. / Fuat, A. / Muñ / oz Hiraldo, E. / Arroba Basanta, M. L. et al. | 2011
- A509
-
PSS42 Evaluation of the Impact of Writing Exercises and Educational Interventions on Quality of Life in Patients With PsoriasisTabolli, S. / Pagliarello, C. / Sampogna, F. / Di Pietro, C. / Abeni, D. / Centro Studi GISED, I. et al. | 2011
- A511
-
ISPOR 14th annual European congress financial disclosure information for research presetnations| 2011
- A521
-
ISPOR 14th Annual European Congress Research Abstracts Author Index| 2011
- A535
-
EX2 Health Care Resource Use Among Patients With Bipolar Disorder From Brazil and Venezuela: Subgroup Analysis of Data From A Large Multinational Longitudinal Study (WAVE-BD Study)Vieta, E. / Baptista, T. / Bifano, M. / Kerr-Corrê / a, F. / Grohs, G. / de Oliveira, I. / Vielma, X. / Montes, C. / Beluche, S. et al. | 2011
- A536
-
QA3 Costo-Efectividad De Dabigatran Versus Warfarina En El Manejo De La Fibrilacion Auricular En ColombiaAlfonso-Cristancho, R. / Herran, S. / Caicedo, M. / Gomez, E. et al. | 2011
- A537
-
VA1 Evaluacion Rápida Del Impacto De La Introduccion De La Vacuna Contra El Rotavirus En ColombiaRico Mendoza, F. A. / Porras, A. / Alvis, N. / De La Hoz, F. / Cediel, N. / Del Rio, F. et al. | 2011
- A538
-
CN2 Cancer De Pulmon Y Tabaco, Analisis Del Costo De Atencion MedicaQuintana Carrillo, R. / Arrieta Rodrí / guez, O. / Zinser Sierra, J. / Correa Acevedo, M. / Mohar Betancurt, A. / Reynales Shigematsu, L. et al. | 2011
- A539
-
HS3 The Economic Burden of Road Traffic Injuries on Health System and Society in BelizeHeredia Pi, I. B. / Pé / rez Nú / ez, R. / Hijar Medina, M. / Jones, S. / Silveira Rodrigues, E. M. et al. | 2011
- A540
-
IN4 Morbidity and Mortality of Community Acquired Pneumonia in Adults in Six Countries in Latin AmericaRosado-Buzzo, A. / Garcia-Mollinedo, L. / Camacho-Cordero, L. / Roberts, C. S. / Mould-Quevedo, J. F. / Trejo-Martinez, A. / Luna-Casas, G. et al. | 2011
- A541
-
RM2 Aplicacion de Modelos De Regresion Con Stata Para El Estudio Del Consumo de Recursos En Unidades De Cuidados Intensivos NeonatalesReyes-Lopez, A. et al. | 2011
- A542
-
PCN3 Estimacion De La Carga De Los Tumores Neuroendocrinos En ColombiaRuiz, A. / Alfonso-Cristancho, R. / Mejia, A. / Gonzalez, D. / Maestre, K. / Herran, S. et al. | 2011
- A543
-
PCN8 Cost-Effectiveness Analysis of an Opioid in Combination with Gabapentin Versus Monotherapy for the Treatment of Neuropathic PainGalindo, L. / Guajardo, J. / Plancarte, R. / Cerezo, O. / Najera, E. / Gonzalez, I. et al. | 2011
- A544
-
PCV4 Analisis Costo Efectividad En El Largo Plazo De Los Stents Liberadores De Farmaco vs Stents Convencionales En Pacientes Con Cardiopatia Isquemica En El ImssGonzalez-Diaz, B. E. / Salinas Escudero, G. / Granados-Garcia, V. / Herná / ndez, I. C. / Abbo, M. C. et al. | 2011
- A545
-
PCV9 Costo–efectividad De Los Ácidos Grasos Omega 3 Como Coadyuvante De La Simvastatina En El Tratamiento De La HipertrigliceridemiaRendon, D. / Ordoñ / ez, J. / Orozco, J. J. et al. | 2011
- A546
-
PDB5 Use of a Discrete Event Simulation Model to Estimate Clinical and Economic Outcomes of Various Self-Monitoring of Blood Glucose Regimes Plus Conventional Pharmacologic Treatment on Type-2 Diabetic Patients in MexicoZanela, O. O. / Cabra, H. A. / Muñ / oz, D. F. et al. | 2011
- A547
-
PDB10 Economic Evaluation of Duloxetine as First-Line Treatment for Painful Diabetic peripheral Neuropathy in MexicoCarlos, F. / Ramí / rez-Gá / mez, J. / Dueñ / as-Tentori, H. / Ramos, E. et al. | 2011
- A548
-
PGI4 Health-Related Quality of Life Improvements in Patients with Active Crohn's Disease Following Treatment with Certolizumab Pegol in the Music Study (NCT00297648)Hé / buterne, X. / Lé / mann, M. / Coteur, G. / Ernault, E. / Colombel, J. F. et al. | 2011
- A549
-
PHP6 Cuadro Básico Y CatÁlogo De Medicamentos Del Sector Salud: Es Actualmente Un referente Para Las instituciones PÚblicas Y/O cumple Con Los Objetivos De Su CreaciónRivera-Peñ / a, G. / Vargas-Palacios, A. / Barraza-Llorens, M. / Gutierrez-Delgado, C. et al. | 2011
- A551
-
PHP18 Impacto De La Participacion Del Farmaceutico Como Parte Del Equipo De Salud En El Primer Nivel De atencion sobre Los CostosMino-Leon, D. / Contreras-Hernandez, I. / Anaya, P. / Reyes, A. et al. | 2011
- A552
-
PHP24 ComparaÇÃo Da qualidade De Vida Entre Pessoas Com DoenÇas Crónicas E Pessoas Da Comunidade Sem DoenÇaPais-Ribeiro, J. / Silva, I. / Pedro, L. / Meneses, R. / Cardoso, H. / Abreu, M. / Melo, V. / Martins, A. / Martins-da Silva, A. / Vilhena, E. et al. | 2011
- A553
-
PHP29 Predictors of Appropriate Use of Insecticide Treated Nets in an Urban Community: The Case of Asokwa Sub-Metropolitan Area, Kumasi, Ashanti, GhanaAgyei-Baffour, P. / Mantey, K. G. / Owusu-Dabo, E. et al. | 2011
- A554
-
PHP36 Historical and Future Drivers for HTA in Reimbursement Systems in Mexico and PolandKirpekar, S. / Shankland, B. et al. | 2011
- A555
-
PHP41 Monitoring of HPV Vaccination Effectiveness Within European UnionBielik, J. / Maruš / ková / E. / Glogowski, C. et al. | 2011
- A556
-
PHP47 AvaliaÇÃo Do Mercado De Antimicrobianos No Brasil: Passo Para ImplantaÇÃo Do Monitoramento E Controle SanitÁrio Em Estabelecimentos FarmacÊuticosMota, D. M. / Araú / jo, M. A. / Santos, A. E. / Cunha, T. R. / Silva, S. F. / Bovi, R. F. / Alaver, R. T. / Albo, G. C. / Cunha, J. A. et al. | 2011
- A558
-
PIN2 Facing Critical Health Events: Economic Impact Of AH1N1 Flu Epidemic In The Mexican Health Sector, 2009-2010Gutierrez-Delgado, C. / Gó / mez-Fraga, S. et al. | 2011
- A559
-
PIN8 Evaluacion Economica De La Extension De Profilaxis Contra CMV De 100 A 200 Dias En Receptores De Trasplante Renal Con Alto Riesgo (D+ / R−)Morales Buenrostro, L. E. et al. | 2011
- A560
-
PMH2 The COST-Effectiveness Of Paliperidone Palmitate Compared To Olanzapine Pamoate In The Treatment Of Schizophrenia In SwedenPudas, H. / Hemels, M. / Mehnert, A. / Druais, S. / Martin, M. et al. | 2011
- A561
-
PMS3 Impacto Economico De La Osteoporosis Y De Las Fracturas Por Fragilidad En El instituto Mexicano Del Seguro socialClark, P. / Carlos, F. / Chico, G. / Galindo-Suarez, R. M. et al. | 2011
- A562
-
PMS8 Cost-Effectiveness analysis of Etanercept versus Available anti-Tnf and Il-6 Blockers for Treating Rheumatoid Arthritis in GuatemalaLutz, M. / Cuesta, G. / Morales, G. et al. | 2011
- A563
-
PMS13 Economic Model of Workplace Impacts of anti-Tnf therapy for Rheumatoid Arthritis in BrazilTeich, V. / Chaves, L. / Birnbaum, H. / Pike, C. / Waryas, C. / Cifaldi, M. et al. | 2011
- A565
-
PRS4 Economic Evaluation of the Use of Palivizumab as prophylactic Treatment for the reduction of Complications associated with respiratory Syncytial Virus in Pre-Term PatientsMayen-Herrera, E. / Buesch, K. / Cortina, D. et al. | 2011
- A566
-
PRS9 Disponibilidad A Pagar Por Un Metodo Efectivo Para Dejar De Fumar: Evidencias A Partir De La Encuesta Global De Tabaquismo En Adultos MÉxico 2009Heredia, I. / Servá / n, E. / Reynales, L. M. / Bautista, S. et al. | 2011
- A567
-
PSY2 ESTIMACIÓn Del Impacto Financiero En La Salud De La POBLACIÓn Mexicana Derivado De La Obesidad Y El Sobrepeso, 2000-2017Guajardo-Barron, V. J. / Gutierrez-Delgado, M. C. et al. | 2011
- A568
-
PSY7 Cost Of Managing Bleeding-Related Episodes (BRE) For Romiplostim Versus Standard Of Care (SOC) In Patients With Chronic Immune Thrombocytopenia (ITP) In MexicoArocho, R. / Northridge, K. / Rivera Hurtado, R. / Chavez, J. G. et al. | 2011
- A569
-
PUK1 Comparison Of Direct Medical Cost Of Dialysis In A Mexican Cohort Either On Peritoneal Or HemodialysisMayen-Herrera, E. / Cortes, M. / Marx, S. E. / Sterz, R. et al. | 2011
- A571
-
ISPOR 3rd Latin America conference disclosure information for reserch presentations| 2011
- A573
-
ISPOR 3rd Latin America Conference Research Abstracts Author Index| 2011
- i
-
Table of Contents| 2011
- I
-
Instructions for Authors| 2011
-
PRM12 An Application of a Proposed Framework for Formulary Listing in Low-income Countries: Case of Côte d'IvoireDiaby, V. / Lachaine, J. et al. | 2011
-
PRM31 Data Pooling of Patient-Reported Outcomes in Clinical Trials: Evaluation of Structual Equation Modelling for Assessing EquivalenceNixon, M. / Burgess, A. J. et al. | 2011
-
PRM37 Assessing the Health Status of Roma Population by Using SF-36 Health Survey: Evidence from GreecePappa, E. / Rotsiamis, N. / Halkiopoulos, G. / Papadopoulos, A. / Niakas, D. et al. | 2011
-
PRM40 Improving the Measurement of quality of Life Based on Fuzzy ScaleChen, P. Y. / Yao, G. et al. | 2011
-
PRM53 Comparing Multiple Propensity Score Adjustment and Traditional Regression Analysis to Assess the Exposure-Outcome Association Using Retrospective Claims DataChatterjee, S. / Aparasu, R. R. / Chen, H. / Johnson, M. et al. | 2011
-
PRM56 Differential Discounting: Questioning the Assumption of Healthcare Resource Fungibility Over TimeO'Mahony, J. et al. | 2011
-
PCN5 Reduced Risk of Chemotherapy-Induced Nausea and Vomiting in Patients with Cancer Treated with Highly Emetogenic Chemotherapy and Antiemetic Prophylaxis With PalonosetronSchwartzberg, L. / Jackson, J. / Jain, G. / Balu, S. et al. | 2011
-
PCN7 The Incidence and Outcome of Febrile Neutropenia in Different Chemotherapy Regimens for Cancer Patients in BelgiumChevalier, P. / Lamotte, M. / Malfait, M. / Marciniak, A. et al. | 2011
-
PCN11 Bevacizumab in Combination with Chemotherapy for the First-Line Treatment of Metastatic Colorectal CancerUbago, R. / Castillo, M. A. / Flores, S. / Beltrá / n, C. et al. | 2011
-
PCN13 Treatment of Patients with Multiple Myeloma (TLN-Registry): A “Real Life” Overview of Treatment by Office-Based Oncologists in GermanyHartmann, H. / Knauf, W. / Abenhardt, W. / Aldaoud, A. / Lerchenmü / ller, C. / Koska, M. et al. | 2011
-
PCN22 Safety Profile of Bevacizumab in Metastatic Colorectal CancerCastillo, M. A. / Ubago, R. / Flores, S. / Rodrí / guez, R. / Beltrá / n, C. et al. | 2011
-
PCN36 The Economic Impact of Treating Early Lung Cancer: A Systematic ReviewMahar, A. L. / Fong, R. / Johnson, A. et al. | 2011
-
PCN44 Cost-of-Illness Study of Human Papillomavirus Cancers in EnglandTempest, M. J. / Thurston, S. / Carroll, S. / Charman, F. / Rajoriya, F. et al. | 2011
-
PCN53 Economic Burden of HPV-Related Head & Neck and Anal Cancers in GermanyRemy, V. / Heitland, W. / Klussmann, J. / Schaedlich, P. / Chen, X. / Moro, L. et al. | 2011
-
PCN58 The Cost of Strong Opioid Treatment of Oncological Pain in the Brazilian Private Health Care SystemPaloni, E. D. / Bonachela Alves, F. / Morais, A. D. / Pereira, M. L. / Bahmdouni, L. et al. | 2011
-
PCN69 Cost-Effectiveness Analysis of Rituximab Maintenance Treatment of Follicular Lymphoma in Patients Responding to First-Line Inmunochemotherapy InductionCastro-gomez, A. J. / Lopez-Guillermo, A. / Rueda, A. / Salar, A. / Rubio-Terré / s, C. et al. | 2011
-
PCN76 Cost-Effectiveness Analysis of Compliance with Clinical Practice Guidelines in Sarcoma Treatment: An Economic Evaluation in Two European RegionsPerrier, L. / Buja, A. / Mastrangelo, G. / Sandona, P. / Ducimetiè / re, F. / Blay, J. Y. / Gilly, F. N. / Siani, C. / Biron, P. et al. | 2011
-
PCN93 Cost-Effectiveness of Treatment with New Agents in Advanced Non-Small-Cell Lung Cancer: A Systematic ReviewBongers, M. L. / Coupe, V. M. / Jansma, E. P. / Smit, E. F. / Uyl-de Groot, C. et al. | 2011
-
PCN114 Cost Effectiveness of Adjuvant Cyclophosphamide in the Treatment of Breast Cancer in SpainWalter, E. / Brennig, C. / Schö / llbauer, V. et al. | 2011
-
PCN115 Cost of Skeletal-Related Events (SREs) in Patients with Bone Metastases to solid Tumours Based on the Health Resource Utilisation (HRU) Collected in a Prospective European Multinational Observational StudyHechmati, G. / Cure, S. / Goué / po, A. / Hoefeler, H. / Lorusso, V. / Lü / ftner, D. / Durá / n, I. et al. | 2011
-
PCN143 Electronic Patient-Reported Outcome Monitoring in Testicular Cancer PatientsGiesinger, J. M. / Oberguggenberger, A. / Kemmler, G. / Gamper, E. / Steiner, H. / Sztankay, M. / Holzner, B. et al. | 2011
-
PCN174 Variations in Drug Administration Costs for Stage III/IV NSCLC in EuropeRosery, H. / Zerwes, U. / Walzer, S. et al. | 2011
-
PDB5 Micro- and Macrovascular Outcomes in Primary Care Patients with Type 2 Diabetes Treated with Insulin Glulisine or Human Regular Insulin: A Retrospective German Database AnalysisKress, S. / Dippel, F. W. / Kostev, K. / Giani, G. / Rathmann, W. et al. | 2011
-
PDB19 Prevalence of Diabetes Mellitus Among Patients with Vascular Complications in PolandFedyna, M. / Mucha, A. / Kapusniak, A. / Bebrysz, M. / Rutkowski, J. / Schubert, A. / Skrzekowska-Baran, I. / Rys, P. et al. | 2011
-
PDB31 Cost of Diabetes in Croatia Impact of Complications on the Costs of Type II DiabetesSaric, T. / Benkovic, V. / Poljicanin, T. / Stevanovic, R. et al. | 2011
-
PDB39 Cost-Effectiveness of Saxagliptin Compared to Sitagliptin for the Treatment of Patients with Type 2 Diabetes Mellitus (T2DM)Hutchings, A. / Tolley, K. / Achana, F. / Brereton, N. J. / Lebmeier, M. / Mesa, O. A. et al. | 2011
-
PDB56 Development of a New Measure for Assessing Health Related Quality of Life (HRQOL) in Patients with Primary Hyperparathyroidism (PHPQoL)Farrerons, J. / Muñ / oz, M. / Puig, M. / Villabona, C. / Webb, S. / Badia, X. et al. | 2011
-
PDB57 Polish Health Care System for Diabetic Patients: The Analysis of Current Health Care System and the Need of Community Pharmacy ImplementationRzeszotarska, O. / Hermanowski, T. R. / Rdzanek, M. et al. | 2011
-
PDB69 Prescription Pattern Study of Type 2 Diabetes Mellitus in IranSoleymani, F. / Farshchi, A. / Haerizadeh, M. et al. | 2011
-
PRS1 COST-Effectiveness Of Varenicline Versus Existing Smoking Cessation Strategies in Brazil from the Public Perspective, Using the Benesco ModelFujii, R. K. / Correia, E. A. / Mould, J. F. et al. | 2011
-
PRS2 The Role Of RX Data in Comparative Effectiveness ResearchVarasteh, L. / Pedan, A. / Asumeng-Denteh, E. et al. | 2011
-
PRS11 Budget Impact Analysis of Immunotherapy in Patients with Birch Allergic RhinitisWesterhout, K. Y. / Verheggen, B. G. / Schreder, C. H. / Doering, C. / Reich, K. et al. | 2011
-
PRS28 Adherence to Current Guidelines for Chronic Obstructive Pulmonary Disease (COPD) in Subjects Treated with Combination of Long-Acting β2-Agonist (LABA), LONG-Acting Muscarinic Antagonist (LAMA) or Inhaled Corticosteroids (ICS)Asche, C. / Leader, S. / Plauschinat, C. / Raparla, S. / Ye, X. / Yan, M. / Young, D. et al. | 2011
-
PRS32 Cost-Effectiveness of Omalizumab in Severe Uncontrolled Allergic Asthma Using Rct and Real-World Evidence in the Dutch SettingStern, S. / van Nooten, F. / Groot, M. / Brown, R. et al. | 2011
-
PSS14 Burden of Disease in Patients With Severe Chronic Hand Eczema in GermanyDiepgen, T. L. / Purwins, S. / Posthumus, J. / Kuessner, D. / Augustin, M. et al. | 2011
-
VA3 A Cost-Effectiveness Analysis of A 10-Valent Pneumococcal Conjugate Vaccine in Children in Six Latin American CountriesGarcí / a Martí / S. / Colantonio, L. / Bardach, A. / Lopez, A. / Caporale, J. / Augustovski, F. / Pichon Riviere, A. / Knerer, G. et al. | 2011
-
PCN1 Selecting a Mix of Prevention Strategies Against Cervical Cancer for Maximum Efficiency with an Optimisation ProgramDemarteau, N. / Gomez, J. A. / Lorenzato, F. / Standaert, B. et al. | 2011
-
PHP12 The Ratio of Public Reimbursement and Patients' Co-Payment in the Financing of Spa Services in HungaryTurcsanyi, K. / Domjá / n, P. / Boncz, I. et al. | 2011
-
PHP48 Os Motivos Que Levam O JudiciÁrio A Determinar Que Os Planos De SaÚde ForneÇam MedicaÇÃo oral Em OncologiaStefani, S. D. / Fonseca, J. R. et al. | 2011
-
PIH5 Replacing MMR By MMRV in Mexico: Assessement of Cost-Effectiveness Based on a Dynamic Transmission ModelOuwens, M. / Macias, M. / Mascareñ / as De Los Santos, A. H. / Gomez, J. A. / Sauboin, C. / Carreñ / o Manjarrez, R. et al. | 2011
-
PRM5 Incorporating Equity Into Developing and Implementing Evidence-Based Clinical Practice GuidelinesEslava-Schmalbach, J. H. / Sandoval Vargas, G. / Mosquera, P. A. et al. | 2011
-
PSY13 Efecto de un Programa de Atención Farmacéutica Para Pacientes Con Sobrepeso Y ObesosAlfonzo, N. / Bastardo, Y. M. et al. | 2011
-
PUK5 ANÁlisis Comparativo De Costos Del Tratamiento Para La Anemia Renal Con Metoxi POLIETILENGLICOL-Eritropoyetina Beta (MIRCERA®) VS. Eritropoyetina ALFAMedina Gó / mez, J. L. et al. | 2011
-
CN1 Mean Versus Median Overall Survival (OS) For Describing Value of New Cancer Therapies: A Case StudyDavies, A. / Briggs, A. / Wagner, S. / Kotapati, S. / Schneider, J. / Ebeid, O. / Levy, A. R. et al. | 2011
-
VI2 A Novel Approach to analysing Value Driver Importance Across Multiple Target Product ProfilesWild, L. / Mukku, S. R. et al. | 2011
-
HG2 Characterizing The Individual Course of Health-Related Quality of Life After Subarachnoid HemorrhageWinter, Y. / Klotsche, J. / Ringel, F. / Spottke, A. / Gharevi, N. / Klockgether, T. / Schramm, J. / Urbach, H. / Wittchen, H. U. / Rehm, J. et al. | 2011
-
HT1 Effectiveness, Efficiency and Budget Impact Affect The Belgian Drug Reimbursement Decision (DRD)Bormans, V. / Van Wilder, P. et al. | 2011
-
HG4 The Value of Heterogeneity for Cost-Effectiveness Subgroup Analysis: Theoretical Framework and ApplicationEspinoza, M. / Manca, A. / Claxton, K. / Sculpher, M. J. et al. | 2011
-
PMD30 Cost-Effectiveness Analysis of Pulmonary Vein Isolation (PVI) Using A Novel Cryo Energy-Based Balloon Catheter: A High-Value procedure for Payers?Tsintzos, S. / Eggington, S. et al. | 2011
-
PMD55 Resource Utilisation related to Urinary Tract infections in Swedish Self-Catheterisation PatientsLö / froth, E. / Bruce, S. / Knutsson, B. / Bö / rstell, T. / Myré / n, K. J. et al. | 2011
-
PHP140 “Troica” Health Care Economics in GreeceKyriopoulos, E. / Mylona, K. / Tsiantou, V. / Kyriopoulos, J. et al. | 2011
-
PSU18 Cost-Utility Analysis of Laparoscopic Versus Open Surgery for Colorectal CancerCallejo, D. / Guerra, M. / Reza, M. / Maeso, S. / Blasco, J. A. et al. | 2011
-
PIN20 Clinical and Economical Impact of Pneumococcal Vaccination in Spanish Adult Population Measured by a Dynamic ModelPradas, R. / Gil de Miguel, A. / Alvaro, A. / Gil-Prieto, R. / Guijarro, P. / Lorente, R. / Antoñ / anzas, F. et al. | 2011
-
PIN35 Costs of Managing Genital Warts in the UKCarroll, S. / Charman, F. / Lanitis, T. / Brown, R. et al. | 2011
-
PIN40 Linezolid Versus Vancomycin for Skin and Soft Tissue Infections by Methicilin-Resistant Staphylococcus Aureus: A Cost Comparison Analysis Under the Public Hospital Perspective in BrazilFujii, R. K. / Takemoto, M. L. / Mould, J. F. / Fernandes, R. A. / Santos, P. M. / Takemoto, M. M. / Lanzara, G. et al. | 2011
-
PIN56 Cost-Effectiveness Model to Evaluate 200-Day vs 100-Day Treatment with Valganciclovir Prophylaxis to Reduce Cytomegalovirus Disease in High-Risk (D+/R-) Kidney Transplant Recipient in SpainFerná / ndez-Rivera, C. / Torre-Cisneros, J. / Guirado-Perich, L. / Oyagü / ez, I. / Ruiz-beato, E. et al. | 2011
-
PIN69 Methodological Challenges for Economic Evaluations of Vaccination Programs: The Case of Pertussis Booster VaccinationMillier, A. / Aballea, S. / Annemans, L. / Quilici, S. et al. | 2011
-
PIN71 Pharmacoeconomic Analysis of Treatment of Community-Acquired Pneumonia (CAP)Zaitsev, A. / Synopalnikov, A. / Tyrsin, O. et al. | 2011
-
PIN76 Cost Effectiveness analysis of Vaccination with 13-Valent (PCV13) and 23-Valent (PPV23) Pneumococcal Vaccines for Senior Adults in BrazilFujii, R. K. / Mould, J. F. / Presa, J. / Jardim, E. / Sato, R. / Strutton, D. R. et al. | 2011
-
PIN89 Do Patients and Physicians Have Similar Preferences Chronic Hepatitis B Treatment Outcomes in Turkey?Mohamed, A. / Johnson, F. R. / Hauber, A. B. / Lescrauwaet, B. / Saylan, M. et al. | 2011
-
PIN91 Sensitivity of Pro's in Evaluating Adverse Events in People Receiving Influenza VaccinationWade, A. / Crawford, G. / Pumford, N. / Mcconnachie, A. et al. | 2011
-
PIN102 National Cost Savings from the Brazilian HIV/AIDS Antiretroviral Universal Access Program: Analysis Versus Canada and AustraliaBecker, R. V. / Teich, V. / Pepe, C. et al. | 2011
-
PIN107 Tobramycin Inhaled Solution Utilization by Cystic Fibrosis Patients: An Analysis with the RAMQ DatabaseLachaine, J. / Beauchemin, C. / Barbeau, M. et al. | 2011
-
PMH9 Prescribing Patterns and Cost of Drugs for Alzheimer's DiseaseTruter, I. et al. | 2011
-
PIN112 Use of Dynamic Models to Measure Health Outcomes of Pneumococcal Vaccination in Spanish Adult PopulationPradas, R. / Guijarro, P. / de Salas-Cansado, M. / Lorente, R. / Antoñ / anzas, F. et al. | 2011
-
PMH5 Empirically-Driven Definitions of “Good” “Moderate” and “Poor” Levels of Functioning in the Treatment of SchizophreniaAscher-Svanum, H. / Novick, D. / Haro, J. / Aguado, J. / Cui, Z. / Anand, H. et al. | 2011
-
PMH11 Psychotropic-Related Hip Fractures Around the World: A Meta-AnalysisYoung, J. / Pepper, G. A. / Oderda, L. / Asche, C. V. et al. | 2011
-
PMH21 Economic Cost of Alcohol and Drug Abuse in Washington State, USAWickizer, T. M. et al. | 2011
-
PMS1 Tumor Necrosis Factor Alpha Inhibitors for the Treatment of Active Ankylosing SpondylitisUbago, R. / Castillo, M. A. / Marí / n, R. / Flores, S. / Rodrí / guez, R. et al. | 2011
-
PMS48 Cost-Utility of Denosumab for the Treatment of Postmenopausal Osteoporosis in SpainDarba, J. / Kaskens, L. / Sorio, F. et al. | 2011
-
PND23 Cost of the Informal Care of Multiple Sclerosis in SpainGubieras, L. / Casado, V. / Romero-Pinel, L. / Matas, E. / Bau, L. / Martí / nez-Yé / lamos, S. / Arbizu, T. et al. | 2011
-
PND27 Economic Analysis of Cost Per Episode of Care for Arm Spasticity and Cervical Dystonia: Comparison of Two Botulinum Toxin A Preparations in 20 CountriesRoze, S. / Marty, R. / Kurth, H. / Godard, A. et al. | 2011
-
PND37 An Examination of Resource Utilization Among Patients with Parkinson'S Disease Treated with Rasagiline or SelegilineGrubb, E. / Castelli-Haley, J. / Lage, M. et al. | 2011
-
PND64 Cost-Minimization Analysis of IFNB-1B and Fingolimod among Multiple Sclerosis Patients in GermanyPan, F. / Goh, J. / Wang, C. / Meinhardt, M. et al. | 2011
-
PUK10 Cost-Effectiveness Analysis of Solifenacin Versus Oxybutynin Immediate-Release in the Treatment of Patients with Overactive Bladder in the United KingdomHart, W. M. / Munro, V. / Retsa, P. et al. | 2011
-
PHP12 Then and Now: The Evolution of International Reference Pricing GloballyBharath, A. / Ando, G. et al. | 2011
-
PHP19 Does Pharmaceutical Price Regulation Affect the Adoption of Generic Competition in the OECD?Varol, N. / Costa-i-Font, J. / McGuire, A. J. et al. | 2011
-
PHP29 Impact of Different Pharmaceutical Distribution Systems on the Access to Pharmaceutical Products in Six European CountriesWalter, E. / Dragosits, A. / Said, M. et al. | 2011
-
PHP52 Inequalities in the Utilization of Home Hospice Services in HungaryTurcsanyi, K. / Domjá / n, P. / Pakai, A. / Gombos, G. / goston, I. / Vas, G. / Molics, B. / liá / s, Z. et al. | 2011
-
PHP91 Patient Safety Activities Associated with Hospital Pharmacy in A Nationwide Survey on Management System for Patient SafetyHirose, M. / Imanaka, Y. et al. | 2011
-
PHP95 Payer Perspectives on Evidence for Formulary Decision Making in the United StatesWang, A. / Baerwaldt, T. / Kuan, R. / Nordyke, R. / Halbert, R. et al. | 2011
-
PHP100 Did Iqwig‘S Drug Appraisals in Connection with G-BA‘S Directives Change Prescribing Behavior of German Physicians?Valentin, M. / Neises, G. / Salek, S. et al. | 2011
-
PHP99 Reimbursing Telemonitoring in Europe: Are Payers Ready?Flostrand, S. / Garde, E. / Toumi, M. et al. | 2011
-
PHP102 Biosimilars: Pricing & Reimbursement in Germany: Key Insights From Sickness FundsChaudhari, S. D. / Bache, B. et al. | 2011
-
PCV2 Evaluation of the prophylaxis Patterns and 90 Day outcome Events in Hospitalized Medically Ill PatientsBaser, O. / Wang, L. et al. | 2011
-
PCV11 Treatment and 12-Month Outcomes of Acute Coronary Syndromes Patients Aged < 75 and ≥ 75 Years Undergoing Percutaneous Coronary Intervention: 14-Country Data on 4545 Patients from the Prospective Antiplatelet Treatment Outcomes Registry (APTOR)Berkenboom, G. / Coufal, Z. / Ferrieres, J. / Mohacsi, A. / Sartral, M. / Belger, M. / Tomlin, M. E. / Norrbacka, K. / Bakhai, A. et al. | 2011
-
PCV34 Improving Global Vascular Risk Management (GVRM) Using the COSEHC Cardiovascular Risk Assessment ToolFerrario, C. / Moore, M. / Simmons, D. / Colby, C. / Exuzides, A. / Panjabi, S. et al. | 2011
-
PCV36 High Dose and Long-Term Safety of Systemic Corticosteroids in the Treatment of Polymylagia Rheumatica and Vasculitis: A Systematic ReviewNyssen, O. P. / Gauthier, A. / Schmitt, C. / Levy, V. / Cognet, M. / Aguiar-ibanez, R. et al. | 2011
-
PCV39 Heparin-Induced Thrombocytopenia Type II in Times of Demographic Changes – Epidemiological and Economic Aspects in GermanySchopohl, D. / Berger, K. / Schramm, W. et al. | 2011
-
PCV40 Budget Impact Model After the Introduction of Vernakalant in SpainNocea Pulfer, G. / Caloto Gonzalez, M. T. / Martí / n Martinez, A. et al. | 2011
-
PCV68 Pharmacogenomic Testing for Warfarin Use in Typical outpatient Settings Lowers Health Care Costs: The Medco-Mayo Warfarin Effectiveness StudyAubert, R. E. / Epstein, R. S. / Yao, J. / O'Kane, D. J. / Tinnirello, J. / Teagarden, J. R. / Moyer, T. P. et al. | 2011
-
PCV72 Long-Term Cost Effectiveness Analysis of Ticagrelor in Patients with Acute Coronary Syndrome from a Polish Health Care PerspectiveMacioch, T. / Niewada, M. / Perkowski, P. / Mellströ / m, C. / Budaj, A. et al. | 2011
-
PCV78 A Cost-Effectiveness Analysis of Clopidogrel Versus Aspirin in Patients with Atherothrombosis in GreeceKourlaba, G. / Fragoulakis, V. / Maniadakis, N. et al. | 2011
-
PCV108 Deriving Utility Values from the General Population for Dronedarone in the Treatment of Atrial FibrillationAdams, J. / Lee, J. / Gonzalo, F. et al. | 2011
-
PCV129 Discrepancies Between Defined Daily Doses and Actual Prescription Patterns in the Polish Setting: the ACE Inhibitors ExampleBorowiec, L. / Szeligowski, M. / Zmigrodzki, B. et al. | 2011
-
PCV131 Cardiovascular Drug Utilization in Relation to Age in Nis RegionKodela, B. / Aleksić / G. / Milić / ević / Velič / ković / R. et al. | 2011
-
PGI14 Resource Use and Cost of Hepatitis C Related Care in BelgiumCaekelbergh, K. / Lamotte, M. / Nevens, F. / Colle, I. / Michielsen, P. / Robaeys, G. / Moreno, C. / Wyffels, V. et al. | 2011
-
PGI15 The Cost and Quality of Life of Hepatitis C in the Netherlandsvan Rooijen, E. M. / Hotho, D. / Agthoven, M. / Van Der Kolk, A. / Hansen, B. E. / Knegt, R. / Uyl-De Groot, C. A. et al. | 2011
-
PIH8 Impact Assessment of Sport- Recreation TrainingSzová / k, E. / Tó / th, x. / Boncz, I. / Jeges, S. / Kriszbacher, I. et al. | 2011
-
PIH13 Generalising the Output of Rotavirus Vaccination Impact Studies: What Can We Learn?Standaert, B. / Strens, D. / Raes, M. et al. | 2011
-
PIH24 Intra Muscular Testosterone Undecanoate (TU) (NEBIDO®) as Testosterone Replacement Therapy (TRT) for Androgen Deficiency in the Aging Male (ADAM) and Diabetes Mellitus Type 2 (DM2) Patients: Brazilian Economic ModelingSilva, A. P. / Santoni, N. B. / Pepe, C. / Paladini, L. et al. | 2011
-
PIH53 Alpha Blockers, 5-Alpha Reductase Inhibitors, PDE-5 Inhibitors and Antimuscarinic Medication Use in US Patients Diagnosed with Benign Prostatic Hyperplasia, and Lower Urinary Tract Symptoms with and Without Erectile DysfunctionBurge, R. / Le, T. K. / Viktrup, L. / Watts, S. et al. | 2011
-
PIH60 Changes in Blood Coagulation Properties Measured by Thrombelastometry During Spiroergometry in Sportsmen and in SportswomenPaska, T. / Kriszbacher, I. / Sipos, E. / Magyarlaki, T. / Sarszegi, Z. / Toth, A. / Jeges, S. / Szabados, S. / Kovacs, G. L. et al. | 2011
-
PSY2 Coexistence of Immuno-Mediated Inflammatory Diseases: an Analysis of the Quebec Administrative Health DatabasesLachaine, J. / Beauchemin, C. / Martel, M. J. / Parison, D. et al. | 2011
-
PSY7 Budget Impact Analysis of Bendamustine in the Treatment of Multiple Myeloma in SpainMateos, M. V. / Collar, J. M. et al. | 2011
-
PSY14 Differences in Outpatient Care Among Fibromyalgia Patients on Duloxetine Versus PregabalinZhao, Y. / Sun, P. / Sun, S. et al. | 2011
-
PSY21 Predictors of Duloxetine Adherence and Persistence in Patients with FibromyalgiaCui, Z. / Zhao, Y. / Fang, Y. / Chen, Y. / Novick, D. / Faries, D. et al. | 2011
-
PSY18 Resource Consumption Evaluation for Ketoprophene, Ketorolac, Parecoxib and Tenoxicam at Orthopedic Surgery Post-Operation in Brazilian Patients from Private Payers PerspectiveFujii, R. K. / Mould, J. F. / Lanzara, G. et al. | 2011
-
PSY30 Cost Effectiveness of Tramadol Versus Diclophenac in Pain Management After Cesarean DeliveryFarshchi, A. / Farshchi, S. / Haghi, S. M. et al. | 2011
-
PSY29 Economic Evaluation of Capsaicin Patch 8% in the Treatment of Neuropathic Pain in AustriaBrennig, C. / Walter, E. / Schö / llbauer, V. et al. | 2011
-
PSY41 Health Status and Health-Related Quality of Life Reported by Females with Bleeding Disorders from the Canadian National Haemophilia RegistryHorsman, J. R. / Rae, C. S. / Furlong, W. / Barr, R. D. / Lillicrap, D. et al. | 2011
-
PSY46 Comparison of Eq-5D and Sf-6D Utilities in Pompe DiseaseKanters, T. / Redekop, W. / Hagemans, M. L. / Van der Ploeg, A. T. / Rutten-van Mö / lken, M. P. / Hakkaart, L. et al. | 2011
-
PSY54 A Cost Estimation of the New Guideline to Treat Bleeding Episodes in Patients with Haemophilia and Inhibitors in IranJaberidoost, M. / Abdollahiasl, A. / Nikfar, S. / Khatibi, M. et al. | 2011
-
PRM28 Bayesian Inference in Mixed Treatment Comparisons (MTC) with Continuous OutcomesOsiewalski, K. / Szmurlo, D. / Rogoz, A. et al. | 2011
-
PRM36 Comparing the Performance of the SF-6D and EQ-5D Across DiseasesFerreira, L. / Ferreira, P. / Pereira, L. et al. | 2011
-
PCN24 Budget Impact Model for Rare Cancer Treatment: Case in Point Cutaneous T-Cell LymphomaAggarwal, S. et al. | 2011
-
PCN38 Economic Evaluation of Darbepoetin Alpha in the Management of Patients with Chemotherapy Induced Anemia (CIA) in GreeceFragoulakis, V. / Maniadakis, N. et al. | 2011
-
PCN41 Hospital Health Care Costs for the Management of HER2-Positive Breast Cancer with Brain MetastasesBaffert, S. / Cottu, P. / Kirova, Y. / Bachelot, T. / Mercier, F. / Le Rhun, E. / Lé / vy, C. / Gutierrez, M. / Madranges, N. et al. | 2011
-
PCN61 Impact of Appropriate Treatment Informed by EGFR Mutation Status on Patient Outcomes from Diagnosis to Death in Advanced Non-Small Cell Lung CancerTeale, C. / Parasuraman, B. / van der Scheer, F. / Langenfeld, M. / Ruff, L. / Hanmore, E. et al. | 2011
-
PCN64 Evaluating the Cost-Effectiveness of the Addition of Rituximab to Chemotherapy in the First Line Treatment of Follicular Lymphoma Patients in the UKRafia, R. / Papaioannou, D. / Stevenson, M. / Rathbone, J. / Woods, H. B. et al. | 2011
-
PCN79 Cost Effectiveness of Erlotinib in First Line Treatment of Advanced Non Small Cell Lung Cancer (NSCLC) in Vulnerable Elderly Patients: An Economical Analysis of a prospective Phase 2 Study (GFPC 0505)Chouaid, C. / Le Caer, H. / Corre, R. / Crequit, J. / Jullian, H. / Falchero, L. / Dujon, C. / Vergnenegre, A. et al. | 2011
-
PCN100 A Cost–Utility Analysis of Degarelix in the Treatment of Advanced Hormone-Dependent Prostate Cancer in ScotlandFisher, D. / Brereton, N. J. / Kildegaard nielsen, S. / Tate, E. et al. | 2011
-
PCN105 Economic Evaluation of Panitumumab and Cetuximab in the Treatment of Patients with EGFR Expressing mCRC with Non-Mutated (Wild-Type) KRAS in Greece: A Cost Minimization AnalysisFragoulakis, V. / Papagiannopoulou, V. / Kourlaba, G. / Ducournau, P. / Maniadakis, N. et al. | 2011
-
PCN129 Mapping the Cancer-Specific EORTC QLQ-C30 and EORTC QLQ-BR23 to the Generic EQ-5D in Metastatic Breast Cancer PatientsKang, H. / Ko, S. K. / Kim, E. J. et al. | 2011
-
PCN151 Value of Outcomes Research to Inform Reimbursment Decision-Making Illustrated by an Observational Study in Chronic Lymphocytic LeukemiaHoltzer-goor, K. / Bouwmans, C. / Schaafsma, M. R. / Uyl-de Groot, C. A. et al. | 2011
-
PCN161 The Lost Art of Needs Assessment: The Case of Hepatocellular Carcinoma (HCC) Control in European CountriesBridges, J. F. / Gallego, G. / Joy, S. M. / Blauvelt, B. M. et al. | 2011
-
PCN168 Cost-Effectiveness Analysis of Different Cervical Cancer Prevention Approaches in the United StatesQiao, N. / Noyes, K. / Dolan, J. G. et al. | 2011
-
PCN169 Differences in the Use of Innovative Anti-Cancer Drugs Among French HospitalsBonastre, J. / Chevalier, J. / Van der Laan, C. / Delibes, M. / De pouvourville, G. et al. | 2011
-
PCN175 Reimbursement of Anticancer Drugs in Canada: What Can We Learn from the Nice New Appraisal Process for Life-Extending End-of-Life Treatments?Cooper, D. / Tarride, J. E. / Goeree, R. et al. | 2011
-
PDB25 Real-World Outcomes of Initiating Two Different Basal Insulin Therapies Via Disposable Pens Among Patients with Type 2 Diabetes in US Employer-Sponsored Health PlansDu, J. / Wei, W. / Xie, L. / Pan, C. / Baser, O. et al. | 2011
-
PDB53 Diabetes Medication Adherence and Glycemic Control in Penang, MalaysiaAl-Qazaz, H. K. / Syed Sulaiman, S. A. / Hassali, M. A. / Shafie, A. A. / Sundram, S. / Saleem, F. et al. | 2011
-
PDB38 Economic Evaluation of Ranibizumab in the Treatment of Visual Impairment Due to Diabetic Macular Edema in AustriaBrennig, C. / Schö / llbauer, V. / Walter, E. / Gallagher, M. / Knudsen, M. S. et al. | 2011
-
PDB43 The Economic Impact of Weight Loss in Patients Newly Diagnosed with Type 2 Diabetes Mellitus (T2DM) and Younger Than Fifty in SwedenWillis, M. / Neslusan, C. / He, J. / Worbes-Cerezo, M. et al. | 2011
-
PDB64 Criteria for Referral of Type 2 Diabetes Patients from Primary Care to Specialized Care and Vice Versa in Spain. Pathways StudyFont, B. / Lahoz, R. / Casamor, R. / Escalada, F. J. / Ezkurra, P. / Ferrer, J. C. / Ortega, C. et al. | 2011
-
PDB68 The Impact of Implementing a Drug Preauthorization Policy in a Primary Care SettingTriki, N. / Shani, S. / Mossinson, D. / Greenberg, D. et al. | 2011
-
PRS14 Estimating the Budget Impact of Introducing Indacaterol in the Treatment Of Chronic Obstructive Pulmonary Disease (COPD) from the Public Payer Perspective in SÃo PauloSuzuki, C. / Silva, N. L. et al. | 2011
-
PRS54 Testing of a Conceptual Model of Asthma in AdolescentsBright, N. / Maguire, L. / Arbuckle, R. / Tabberer, M. / Dale, P. et al. | 2011
-
PRS63 Faciliators and Barriers Associated with the Use of Pharmacological – Behavioral Combination Therapy to Smoking CessationUttiyung, R. / Layton, M. R. et al. | 2011
-
PRS70 Real World Evaluation of Different Smoking Cessation Service Models in EnglandMardle, T. / Merrett, S. / Wright, J. / Percival, F. / Lockhart, I. / Marshall, S. et al. | 2011
-
PSS12 C-Reality (Canadian Burden of Diabetic Macular Edema Observational Study): Three-Month FindingsBarbeau, M. / Gonder, J. / Walker, V. / Maschio, M. / Zaour, N. / Li, R. et al. | 2011
-
PSS19 Glaucoma Management Cost as A Function of Disease Stage and Treatment ChangesGerlier, L. / Shlaen, R. / Lorenz, K. / Lamotte, M. / Verboven, Y. / Pfeiffer, N. et al. | 2011
-
VA4 Costo-Efectividad De La Vacuna Contra El Vph Subtipos 16 Y 18 En MéxicoMuciñ / o-Ortega, E. / Valencia-Mendoza, A. / Flores-Leonard, Y. / Bertozzi Kenefick, S. M. et al. | 2011
-
CN3 Cost Effectiveness of Liposomal Doxorubicin Versus Paclitaxel for the Treatment of Aids-KsRaimundo, K. / Asche, C. et al. | 2011
-
IN2 Chronic Hepatitis C Treatment For Genotype 2 Or 3: COST-Effectiveness Analysis of Peg as First Line Treatment With the Brazilian ProtocolBlatt, C. R. / Storb, B. H. / Mü / hlberger, N. / Wurm, J. / Farias, M. R. / Siebert, U. et al. | 2011
-
RM1 Comparing the Use of Dynamic and Static Infectious Disease Models in Latin America with North America, Europe, Asia and other RegionsVargas-Palacios, A. / Stevenson, M. / Dueñ / as, A. / Wailloo, A. et al. | 2011
-
PCN9 Economic Evaluation of Panitumumab vs Cetuximab in Patients with Colorectal Carcinoma (CRCM) with Non-Mutated (WILD-TYPE) Kras After Failure of Chemotherapy Regimens in MexicoArocho, R. / Hurtado, R. R. et al. | 2011
-
PCV10 Un Estudio De Minimizacion De Costos Para Evaluar El Tratamiento Con Metoprolol En Pacientes Con Hipertension Arterial En MéxicoLopez, J. A. / Briones, B. et al. | 2011
-
PDB2 Calidad De Prescripcion De Hipoglucemiantes orales En Una Unidad Medica Familiar: Centro, Tabasco, MÉxico, 2009Zavala-Gonzá / lez, M. A. / Posada-Aré / valo, S. E. / Barrera-Olá / n, L. / Ló / pez-Mandujano, C. / Miró / n-Carrera, M. T. et al. | 2011
-
PHP5 Modelo Teorico De Un Consumidor: Seleccion Entre Un Biosimilar Y Un Biotecnologico De Patente Basado En PreferenciasLechuga, D. et al. | 2011
-
PHP8 Measuring Adherence to Drug Treatment in Mexican Patients: A Systematic ReviewUc-Coyoc, R. / Pé / rez-Reynaud, A. G. / Coello-Reyes, L. A. / Rodriguez-Dí / az Ponce, M. A. et al. | 2011
-
PHP20 Economic Evaluation of Poison Control Centers: A Systematic ReviewGalvao, T. F. / Silva, E. N. / Silva, M. T. / Pereira, M. G. et al. | 2011
-
PHP31 Analisis Costo Efectividad Sectorial De 45 Intervenciones Sanitarias En ChileVallejos, C. / Castillo, M. / Puebla, S. / Orellana, J. / Reveco, R. / Valdé / s, P. / Alarcó / n, A. / Merino, W. et al. | 2011
-
PHP34 Necesidades De información Y formación Sobre Farmacoeconomia E Investigación De Resultados Para Profesionales Y Estudiantes De Farmacia Del Oriente VenezolanoAdesso, G. / Bastardo, Y. et al. | 2011
-
PHP50 The Valuation of End-of-Life Health GainsCairns, J. et al. | 2011
-
PIN10 Exchange Rate Or Power Purchase Parity For Economic Evaluation: Estimating The Costs Of Rotavirus Vaccination In A Six-Year Period Considering Data From Mexican ChildrenGranados-Garcia, V. / Salinas-Escudero, G. / Martinez-Valverde, S. et al. | 2011
-
PMS9 What is the Value of the New Kid on the Block?: tocilizumab versus Abatacept for Rheumatoid Arthritis in ColombiaAlfonso-Cristancho, R. / Aiello, E. C. / Roa, C. N. / Valencia, J. E. et al. | 2011
-
PRM6 Translation of Patient-Reported Outcomes Measures Translatability Review And Item DefinitionArnold, B. J. / Correia, H. / Pé / rez, B. / Lent, L. et al. | 2011
-
PRS5 Cost-Effectiveness of Varenicline vs Existing Smoking Cessation Strategies in Dominican republic Using the Benesco ModelLutz, M. / Morales, G. / Cuesta, G. et al. | 2011
-
PR2 Value-Based Pricing in the UK: Developing an Evaluation Framework for Burden of IllnessEasley, C. / Tang, J. et al. | 2011
-
UT4 Comparison Of The Performance Of EQ-5D and SF-6D In Patients With Chronic Pain –Results From 3 Randomized Controlled TrialsObradovic, M. / Lal, A. / Liedgens, H. et al. | 2011
-
RS2 Cost-Effectiveness of End-of-Life, Life-Extending Interventions: NICE's Cost-Effectiveness Threshold ExploredHamerslag, L. / Haynes, S. / Kusel, J. / Costello, S. et al. | 2011
-
PMD5 Diagnostic Accuracy of Clinical Characteristics following Minor Head injury: A Systematic review and Meta-analysisPandor, A. / Harnan, S. E. / Goodacre, S. W. / Pickering, A. / Fitzgerald, P. / Rees, A. C. et al. | 2011
-
PMD18 Mast (Minimal Access Spinal Technologies) versus Open Surgery: Activity-Based Cost analysis of Spinal Fusion procedure from Hospital PerspectiveCorbo, M. / Marchese, E. / Ihara, Z. et al. | 2011
-
PMD23 Characterization of Focal Liver Lesions by Contrast-Enhanced Ultrasound in the Netherlands: An Economic EvaluationZaim, R. / Taimr, P. / De knegt, R. / Redekop, W. / Uyl-de Groot, C. et al. | 2011
-
PMD24 Cost-Effetiveness of 3M ™ Coban 2 ™ Compression System in the Treatment of LymphoedemaPurwins, S. / Herberger, K. / Rustenbach, S. J. / Augustin, M. et al. | 2011
-
PMD35 Cost-Effectiveness Analysis of the Corail Hip System for Primary total Hip Arthroplasty in SpainCrespo, C. / Espallardo, O. / Graefenhain De Codes, R. / Nieves, D. et al. | 2011
-
PMD36 Cost-Effectiveness of the Ex-Press Glaucoma Filtration Device in the NetherlandsDe jong, L. / Lafuma, A. / Aguade, A. S. / Clé / ment, O. / Berdeaux, G. et al. | 2011
-
PMD39 Cost Effectiveness Analysis of Intrathecal Baclofen Therapy (Tricumed™) Versus Medical Treatments for Severe Spasticity in TurkeyMalhan, S. / Oksuz, E. / Ozsezer, Y. et al. | 2011
-
PMD43 An Evidence-Based Microsimulation Model for Chronic Graft versus Host Disease in SpainSierra, J. / Perez-Simon, J. / Crespo, C. / Rodrí / guez, J. / Brosa, M. et al. | 2011
-
PMD71 Resource Use Caused by in-office Follow-up Visits for Cardiac Implantable Electrical Devices (CIED) in Germany and the United KingdomSmala, A. / Gessler, M. / Vogtmann, T. et al. | 2011
-
PMD77 Components of Health Technology Assessment for Radiology in ChileCuenca, D. / Leisewitz, T. / Bryon, A. / Rascovsky, S. / Strappa, V. et al. | 2011
-
PSU2 Comparison of Seizure and Hydrocephalus and Other Clinical Conditions Before and After Subependymal Giant Cell Astrocytoma Surgery in Patients with Tuberous Sclerosis ComplexSun, P. / Liu, Z. / Rogerio, J. / Guo, A. / Garay, C. / Kohrman, M. et al. | 2011
-
PSU9 Incidence of Major Surgeries in Patients with Metastatic Colorectal CancerWang, S. / Gao, S. K. / Barber, B. / Wagner, V. / Zhao, Z. et al. | 2011
-
PIN15 Trends in Varicella-Zoster Incidence in the Netherlands & Boosting Effect Within HouseholdsOostvogels, A. J. / Gumbs, P. / Fortanier, A. / Van Steenwijk, P. C. / Postma, M. J. et al. | 2011
-
PIN46 Cost-Effectiveness and Public Health Impact of Pneumococcal Vaccination in MalaysiaLee, K. K. / Hong, L. W. / Roberts, C. S. / Lee, V. W. / Hon, E. / Strutton, D. R. et al. | 2011
-
PIN49 Cost-Effeectiveness of Earlier Initiation of First Line Combination Antiretroviral Therapy in an Urban Outpatient HIV Clinic in UgandaKuznik, A. / Sempa, J. / Ssennono, M. / Hermans, S. / Castelnuovo, B. / Lamorde, M. / Semeere, A. / Auerbach, B. / Sowinski, S. / Ssewankambo, F. et al. | 2011
-
PIN86 Interim Results on Adherence to Treatment of Chronic C Hepatitis Monoinfected and HCV/HIV Co-infected Patients Assessed by the Adhepta QuestionnaireSolà / R. / Martí / n-Suá / rez, J. M. / Castellano, G. / Tural, C. / Pé / rez-Á / lvarez, R. et al. | 2011
-
PMH10 Exposure to Antipsychotic Medications During Four Year Periods Following Treatment Initiation among Children Under Six Years OldConstantine, R. J. / Jentz, S. / McPherson, M. et al. | 2011
-
PMH32 Cost-Effectiveness of Agomelatine in the Treatment of Major Depressive Episodes in ThailandPrukkanone, B. / Kongsuk, T. et al. | 2011
-
PMH54 Quality of Life as a Predictor of Clinical Outcome: Example in SchizophreniaMillier, A. / Boyer, L. / Perthame, E. / Aballea, S. / Auquier, P. / Toumi, M. et al. | 2011
-
PMH82 Examining Variability in Depression Among Pre-Retirees: Innovative Analytic Methods Applied to Observational DataStull, D. E. / Houghton, K. et al. | 2011
-
PMS16 Potential Cost Saving of Epoetin Alfa Compared to Autologous Blood Donation or to No-Blood-Conservation-Strategy Before Elective Hip or Knee Surgery Due to reduction in Allogeneic Blood Transfusions and Its Side EffectsTomeczkowski, J. / Frietsch, T. / Mü / ller, A. / Schleppers, A. / von Heymann, C. et al. | 2011
-
PMS23 Analysis of Indirect Costs for Care of Rheumatoid Arthritis Patients Using Large Cohort Database, Iorra, in JapanIgarashi, A. / Hoshi, D. / Tanaka, E. / Inoue, E. / Nakajima, A. / Momohara, S. / Taniguchi, A. / Yamanaka, H. / Tsutani, K. et al. | 2011
-
PMS22 The Burden of Illness of Osteoporosis in CanadaTarride, J. E. / Hopkins, R. / Leslie, W. D. / Morin, S. / Adachi, J. / Papaioannou, A. / Bessette, L. / Brown, J. P. / Goeree, R. et al. | 2011
-
PMS43 Cost-Minimization Analysis of Collagenase Clostridium Histolyticum Compared with Fasciectomy in Patients with Dupuytren'S Contracture in PortugalInê / s, M. / Silverio, N. M. / Erdogan-Ciftci, E. et al. | 2011
-
PMS44 Cost-Effectiveness of Denosumab in the Treatment of Postmenopausal Osteoporosis in ScotlandDavies, A. / Compston, J. / Ferguson, S. / McClosky, E. / Shearer, A. / Taylor, A. et al. | 2011
-
PMS62 Improved Fatigue and Physical Function are Correlated with Health-Related Quality of Life in Psoriatic Arthritis Subjects Treated with Apremilast: Results from a Phase 2, Randomized, Controlled StudyStrand, V. / Hu, A. / Zhang, F. et al. | 2011
-
PND2 Cost Offsets and Gains in Health Effects in the Treatment of Relapsing–Remitting Multiple Sclerosis with Laquinimod: An Analysis Based on the Allegro TrialEkman, M. / White, R. E. / Buck, P. E. / Justo, N. / Lindgren, P. et al. | 2011
-
PND12 the Cost of Corticosteroid-associated Adverse Events in Systemic Lupus ErythematosusShah, M. / Chaudhari, S. / Mclaughlin, T. / Kan, H. K. / Bechtel, B. / Dennis, G. / Molta, C. T. et al. | 2011
-
PND22 A Cost-of-Illness Analysis of Myasthenia Gravis in GreeceAthanasakis, K. / Glava, V. / Zacharis, M. / Zouvelou, V. / Evdokimidis, I. / Kyriopoulos, J. et al. | 2011
-
PND33 Cost Minimization Analysis of Fingolimod Compared to Natalizumab in Patients with Relapse Remitting Multiple Sclerosis in the NetherlandsVerheggen, B. / Treur, M. / Groot, M. et al. | 2011
-
PND57 Effect of Treatment Timing on Risk of Institutionalization Among Patients with Alzheimer'S DiseaseGeldmacher, D. S. / Kirson, N. Y. / Birnbaum, H. G. / Kantor, E. / Eapen, S. / Joish, V. N. et al. | 2011
-
PHP32 Market Access Variation for Lifestyle Disease Drugs in EuropeBastian, A. W. / Gea-Sanchez, S. / Tangari, M. et al. | 2011
-
PHP56 The Emergent Role of the Specialist Pharmacist as an Important Stakeholder in Market AccessEdathodu, A. S. / Ismail, A. et al. | 2011
-
PHP73 Government Reduces Public Pharmaceutical Expenditure in Hungary: Rational Decisions in Challenging Economic times?Inotai, A. / Meré / sz, G. / Kalo, Z. et al. | 2011
-
PHP77 Exploring Different HRQOL Measures as Predictors of Future Health Care ExpendituresGatwood, J. / Erickson, S. et al. | 2011
-
PHP81 Funding Sources Analysis Results (Regional and Federal Levels) of Pharmaceutical Markets per Regions of Russian FederationBorisov, D. / Pechenkin, A. et al. | 2011
-
PHP85 A Systematic Review of Automated Dose Dispensing in Primary Health CareSinnemä / ki, J. / Sihvo, S. / Isojä / rvi, J. / Blom, M. / Airaksinen, M. / Mä / ntylä / A. et al. | 2011
-
PHP115 Preliminary Analysis of the Unwritten Decision Rules Behind the French Transparency Commission'S Assessment of DrugsToumi, M. / Michel, M. / Mraidi, M. / Rahmouni, A. / Duvillard, R. et al. | 2011
-
PHP114 Performance Indicators of Intensive Care in HungaryVarga, S. / Gresz, M. / Boncfö / ldi, K. / Sebestyé / n, A. / Kriszbacher, I. / Bogá / r, L. / Boncz, I. et al. | 2011
-
PHP116 Clincal and Economic Evidence Bases for Health Technology Assessment: A Comparison of Three JurisdictionsWalter, J. W. / Spinner, D. S. / Birt, J. / Bowman, L. / Mauskopf, J. / Drummond, M. / Copley-Merriman, C. et al. | 2011
-
PHP135 Evaluation of Cost Containment Interventions Introduced on the Community Drug Schemes in Ireland Using A National Prescrption Claims DatabaseUsher, C. / Tilson, L. / Bennett, K. / Barry, M. et al. | 2011
-
PHP153 Some Shortages and Alternatives to the Patent System for PharmaceuticalsAntonanzas, F. / Juarez-Castello, C. A. / Rodriguez-Ibeas, R. et al. | 2011
-
PHP152 The Administrative Burden of Patient Access Schemes in the Changing UK Health Care System: A Follow Up StudyHaynes, S. / Timm, B. / Hamerslag, L. / Costello, S. et al. | 2011
-
PHP154 Iranian Health System Decentralization Reform: A Qualitative Study of Various Levels of Autonomy Granted to Public Hospitals Affilieated with Ministry of Health in IranJafarisirizi, M. / Ibrahimipour, H. / Dehnavieh Tijang, R. et al. | 2011
-
PHP155 Review of Cost Effectiveness Models of High Budget Impact DrugsAggarwal, S. et al. | 2011
-
PCV17 Cost-Effectiveness Analysis of Bosentan and Sildenafil Compared with Standard therapy in Treatment of Primary Pulmonary Arterial Hypertension in Russian FederationOmelyanovsky, V. / Avxentyeva, M. / Krysanov, I. / Goryaynov, S. / Ivakhnenko, O. / Tsfasman, F. M. et al. | 2011
-
PCV41 The Budgetary Impact of Implementing A Telehealth Home Monitoring System for Chronic Heart Failure Patients in a Typical UK Primary Care TrustAlmond, C. / Latimer, J. / Brereton, N. J. / Chapman, A. M. et al. | 2011
-
PCV75 Cost-Effectiveness of Optimizing Use of Statins in Australia: Using Outpatient Data from the REACH RegistryAdemi, Z. / Reid, C. / Hollingsworth, B. / Stoelwinder, J. / Steg, G. / Bhatt, D. / Liew, D. et al. | 2011
-
PCV95 Economic Analysis of Interventions to Improve Control of Blood Pressure in Nigerian HospitalsEkwunife, O. I. / Aguwa, C. N. / Ezenduka, C. C. et al. | 2011
-
PCV103 Estimating the Impact of Adherence to Allopurinol Therapy on Cardiovascular Outcomes in Gout Patients Using the Health Improvement Network (THIN) General Practice DatabaseRabi, R. / Elliott, R. / Quinn, C. et al. | 2011
-
PCV106 Predictors of Health Related Quality of Life in a Hypertensive PopulationSaleemx, F. / Hassali, M. A. / Shafie, A. A. / Bashir, S. et al. | 2011
-
PCV120 Quality of Life in Chronic Symptomatic Heart Failure Patients in Spain, insight from the Inoescaro StudyMarti, B. / Delgado, J. / Oliva, J. / Llano, M. / Pascual, P. / Comin, J. / Grillo, J. J. / Diaz molina, B. / Culebras, J. / Martí et al. | 2011
-
PCV122 How Patients with Chronic Stable Angina Perceive and Live with their Disease on an Everyday Basis?Benmedjahed, K. / Arnould, B. / Guillemin, I. / Alegre, P. et al. | 2011
-
PCV133 Baseline Characteristics, Intervention Modalities and Utilization of Evidence Based Medications Among ACS Patients: Does Presence of Diabetes Affect the Presentation as Well as Management Scenario for ACS? – Results from Single Centric Cross-Sectional Study from IndiaShah, B. / Mahajan, S. / Patel, B. / Parikh, K. et al. | 2011
-
PCV135 Low Lipoprotein Cholesterol Goal Attainment in Dyslipidemic Patients with Existing Statin therapy: A Chart Extraction-Based ApproachIvanova, J. / Frois, C. / Bae, J. P. / Boykin, S. D. / Mccracken, R. / Molife, C. / Waldman, T. / Zhao, Z. et al. | 2011
-
PCV138 Using a Population- Based, Budget- Constrained, Cost-Effectiveness Model to Assess the Health and Economic Impacts of Using Statins for Primary Prevention Based on the Jupiter Trial intended Use PopulationArbel, R. / Greenberg, D. et al. | 2011
-
PCV141 Current Management Pathway of Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention in Greece. Results from Aptorii StudyPavlides, G. / Drossinos, V. / Dafni, C. / Antoniadis, A. / Routoulas, T. / Zarifis, I. / Chamouratidis, N. / Tsikaderis, D. / Nanas, J. / Kaprinis, I. et al. | 2011